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ABSTRACT 
 
Many diagnostic tests for disease management and overall health monitoring 
provide only an instantaneous measurement of the patient’s state of health, leaving 
intermediate fluctuations in biochemistry levels undisclosed. Often, fluid samples are 
collected periodically and analyzed using ex vivo assays. Diabetes is a prime example of 
this enigma where knowledge of blood biochemistry fluctuation patterns in real time 
could allow patients to make more informed treatment and lifestyle decisions.  
In recent years, hydrogels have been investigated as fully implantable biosensors 
by functionalizing them with enzymes and long-lifetime phosphors. However, 
maintaining a proper balance between enzyme stability and substrate transport when 
implanted has prevented preclinical proof of concept using this enzyme/phosphor 
sensing platform. This work explores the effect of matrix chemistry on enzyme stability 
and substrate transport and demonstrates the first noninvasive glucose tracking in 
porcine models by measuring luminescence lifetime instead of intensity.  
The first aim of this work focuses on poly(HEMA-co-AAm) matrices, 
characterizing them as glucose sensors in vitro and in vivo. A copolymer hydrogel 
containing 75:25 HEMA:AAm responded to up to 167 mg/dL of glucose in vitro and 
tracked real-time porcine blood glucose levels two hours after implantation, the first-
reported real-time glucose tracking measuring phosphorescence lifetime using a 
noninvasive interrogation method. The second aim of this work employs alternative 
monomers such as dimethylacrylamide, N-vinyl pyrrolidone, and a 3-
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[Tris(trimethylsiloxy)silyl]propyl methacrylate to investigate enzyme stability and 
optimize substrate transport. These studies revealed that gels containing 
dimethylacrylamide and N-vinyl pyrrolidone provide the most enzyme stability, 
preserving between 60 and 93% of the original apparent activity after one week of 
incubation, but matrix inhomogeneities from adding silicone monomers can decrease 
sensor dynamic range by 56%. Finally, hybrid inorganic-organic interpenetrating 
network hydrogels were developed to prevent silicone phase separation in the hydrogels. 
These materials increased oxygen transport by up to 256% in vitro compared to 
pHEMA-based oxygen sensors and responded to modulated inspired oxygen in porcine 
models over 72 days. Hybrid sensors made with tissue-integrating inverted colloidal 
crystal architectures revealed minimal fibrosis in vivo with loosely woven collagen 
surrounding the implants, demonstrating promise for these hybrid materials as long-term 
implantable biosensors.   
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NOMENCLATURE 
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IPN Interpenetrating network 
 ix 
 
LbL Layer by layer 
MEHQ Hydroquinone monomethyl ether 
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PBS Phosphate-buffered saline 
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SEM Scanning electron microscopy 
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Tg Glass transition temperature 
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λex Excitation wavelength 
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1. INTRODUCTION 
 
1.1. Current Standard of Healthcare—Diagnostics and Disease Management 
Traditionally, the standard of healthcare in the US has been one of a highly 
centralized structure, requiring many patients to travel long distances to receive 
information about their state of health and to receive treatment. High costs, fragmented 
health status information, and delayed treatment are associated with such a healthcare 
structure [1]. Recently, efforts have placed emphasis on a paradigm shift from a highly 
centralized standard of care in the clinic to a highly networked structure, placing the 
patient at the center and connecting the patient and healthcare provider in an on-demand 
fashion [2-4]. Researchers are utilizing remote healthcare and telemedicine to pave the 
way for personalized medicine, a field that has been deemed the “Holy Grail” of 
revolutionized healthcare [5]. Biosensors capable of rapid, on-demand analyte detection 
are essential to realizing this healthcare shift, allowing real-time tracking of biomarker 
concentrations in order to take therapeutic action in a timely manner. 
To manage many chronic diseases, fluid samples are collected periodically and 
analyzed using ex vivo assays. There are clinical assays for diagnosing and managing 
numerous chronic diseases such as hypothyroidism, cardiac disease, and cancer, among 
others [6]. Assays to detect numerous biomarkers have been developed for use in the 
clinic by sampling biological fluid (e.g., urine, saliva, or blood). These methods use 
assays such as Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and 
Enzyme-Linked Immunosorbent Assay (ELISA). Biomarkers are detected, and signal 
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levels are correlated to a biomarker concentration predictive of the patient’s state of 
health [7]. Based on these readings, the patient can then take corrective action to manage 
his or her disease, if necessary. 
While many assay methods have been developed to detect biomolecules for a 
variety of diseases, the aforementioned methods are often confined to clinical settings. 
Not only does this restrict disease diagnosis and management to highly developed areas 
of society, but it also requires time to process the biological samples, sometimes on the 
order of days to a week, delaying transfer of knowledge to the patient to take corrective 
action. Some diseases benefit from more frequent testing, causing the rise of point-of-
care devices such as the glucometer and pregnancy test, which are the two most common 
and commercially available. Point-of-care devices offer the patient more control over 
managing his or her disease by preventing the management method from being restricted 
solely to a clinical setting [8]. 
1.2. Point-of-Care Disease Management and Continuous Glucose Monitoring 
Efforts are being made to deliver chronic disease management at the point of care 
[9, 10], but some chronic diseases are more effectively managed by continuously 
monitoring biochemistry. Diabetes mellitus affects nearly 30 million children and adults 
in the US, with 1.7 million Americans being diagnosed each year. At this rate, it is 
estimated that one in every three adults will have diabetes by the year 2050 [11-14]. 
Additionally, $200 billion is spent annually on diabetes healthcare management. A long-
lasting, continuous glucose monitoring (CGM) system is needed to better the welfare of 
individuals affected by this chronic disease through improving the precision of glycemic 
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control and patient compliance [15, 16]. Currently, a few CGM models are commercially 
available but contain rigid electrochemical probes that are easily recognized as foreign 
material by the body and cause significant inflammatory responses, despite efforts to 
make these devices more flexible [17-19]. Additionally, inserting these devices requires 
creating a percutaneous wound, which provides a pathway to infection throughout the 
entire time the device remains in vivo. Because of dynamic tissue environments 
surrounding the sensor, the percutaneous nature of these CGMs requires frequent probe 
calibration (up to four times daily) throughout the device’s operational lifetime [20, 21]. 
Although made to be relatively small, commercially available CGMs all require an 
external transmitter that sits on the surface of the skin, subjecting the sensor to 
micromovements that cause more tissue trauma, discomfort, and infection. The 
cumulative effect of these factors leaves patients with a very narrow window within 
which they can obtain reliable real-time blood glucose concentration measurements and 
real-time profiles. Hydrogels have been investigated for long-term implantable 
biosensing applications by functionalizing them with enzymes and luminescent dyes to 
create a softer, fully implantable alternative to the commercially available 
electrochemical CGMs [22-27]. 
1.2.1. Mobile Healthcare and Personalized Medicine 
With the advent of mobile technology, one rising field called mobile health 
(mHealth) has grown in the last decade [6]. In principle, incorporating mobile devices 
into a disease management regimen could allow for even more frequent and seamless 
testing of biomarker levels by allowing data transfer to a smartphone, requiring even less 
 4 
 
hands-on time from the patient; however, unless a sensor is continually present in the 
body, this vision of seamless integration is still somewhat curtailed. Even with the 
advent of portable, handheld, and point-of-care devices, patients endure painful, repeated 
fingersticks, and the limitations of discrete time-point analysis do not provide caregivers 
or patients the ability to monitor systemic fluctuations over time [5, 24]. A prime 
example of this is diabetes, where knowledge of blood glucose dynamics helps inform 
decisions about treatment and lifestyle; yet, there are other situations where tracking 
biochemistry may also lead to improved outcomes [21, 28-32]. 
1.2.2. Factors Affecting Continuous Monitoring Device Operational Lifetime 
Several methods of blood glucose detection employ the enzyme glucose oxidase 
(GOx) to catalyze the reaction of glucose in the presence of oxygen and water into 
gluconic acid, producing hydrogen peroxide as a byproduct. Often, GOx is immobilized 
on a solid substrate, polymer film, or gel to enhance stabilization. Based on the method 
of immobilization, several factors could play a role in sensor performance longevity, 
including enzyme deactivation and the substrate (oxygen and glucose) diffusion balance 
through the immobilization platform [17, 22, 27, 33, 34]. Therefore, both substrate 
transport and the ability of GOx to catalyze the reaction converting glucose into its 
oxidized form gluconic acid (i.e., the “apparent enzyme activity”) can affect sensor 
readings. 
Causes for enzyme deactivation include prolonged exposure to both glucose and 
oxygen, which produce peroxide and acid. Hydrogen peroxide has been shown to 
irreversibly deactivate GOx, especially when GOx is in its reduced form [35-43]. In 
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addition, acid production can affect the apparent activity of the enzyme, even without 
denaturing it [44, 45]. If overall substrate transport is high, GOx will turn over both 
substrates quicker, leading to quicker GOx deactivation and potentially ultimately 
decreasing the device longevity. The in vivo environment presents additional hurdles to 
sensor performance longevity because of the elevated temperature of the body (37°C vs. 
25°C at room temperature), reactive oxygen species (ROS) such as hydrogen peroxide 
secreted by macrophages, and end-stage fibrosis around the implant, providing an 
additional diffusion barrier to oxygen and glucose [24]. 
However, different reaction-diffusion balances yield different sensor response 
profiles, depicted by hypothetical data in Figure 1-1. For example, if sufficient enzyme 
apparent activity exists but the glucose transport is too low relative to oxygen, the signal 
sensitivity is diminished because there is not enough access to glucose to drive the 
reaction, as depicted in Figure 1-1A. On the other hand, if enzyme activity is sufficient 
but glucose transport is too high relative to oxygen transport, the signal level will 
increase rapidly, and high glucose levels will be undetectable because the optical  
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range of the dye will be saturated quickly (i.e., local oxygen levels depleting faster than 
they can be replenished, rendering oxygen the limiting substrate of the GOx-catalyzed 
reaction, Figure 1-1B). Thirdly, if substrate diffusion is balanced but too little active 
enzyme is present, the enzyme will react at its maximum velocity in the middle of the 
glucose challenge, and insufficient catalysis will be present to transduce signal levels for 
the entire range (hypo-, eu-, and hyperglycemic levels), depicted in Figure 1-1C. 
Moreover, a properly balanced diffusion and reaction system (Figure 1-1D) is necessary 
to optimize the sensor dynamic range and sensitivity across all glucose levels (0 to 400 
mg/dL). 
A B 
C D 
Figure 1-1: Various scenarios of sensor responses over the physiologically 
relevant glucose ranges with different reaction/diffusion balances. Responses are 
based on normalized signal levels of hypothetical data. 
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1.3. Criteria for Long-Term Fully Implantable Continuous Monitoring Devices 
Therefore, to realize a long-term fully implantable optical glucose biosensor, 
each component of sensor performance (diffusion and reaction) must be considered. In 
order to improve device operational lifetime in vivo, a need exists for a hydrogel that 
imparts long-term enzyme stability as well as provides adequate substrate transport 
balance, even when accounting for end-stage foreign body response (FBR). There are 
two potential approaches to this problem: 1) rational design and 2) combinatorial, brute 
force. The former method requires knowledge of fundamental properties of enzymes and 
their interaction with different solvents and solutes, as well as mechanisms of 
deactivation following immobilization and substrate transport. The latter does not 
require any a priori understanding of enzyme-material interactions and substrate 
transport, but is a time-consuming and expensive affair involving screening of a large 
number of material candidates to search for a global or local optimum. Unfortunately, 
there is a dearth of knowledge on enzyme-hydrogel interactions, described in further 
detail in later chapters, from which to directly draw conclusions that could lead to 
optimal material selection for this application. Thus, there is a need to generate better 
understanding of these fundamental effects as well as develop efficient methods of 
evaluating candidate materials for their suitability as an enzyme-encapsulating matrix. 
The experiments described herein are designed to quantify substrate diffusion 
and apparent enzymatic activity/stability, identifying relationships between each 
parameter to identify promising formulations in vitro. Additionally, formulations are 
challenged in porcine models to determine the effectiveness of translating rational sensor 
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designs on the benchtop to an in vivo environment to further refine the design of 
hydrogel matrices for long-term sensor function. 
The following chapters of this dissertation are organized to present results of 
studies in a logical progression. Several of the studies presented herein have been 
submitted for publication or are available online and in print. In Chapter 2, the 
background for this work is provided, portraying prior work on using polymeric 
biomaterials in biosensor design. Chapters 3 to 5 describe the characterization and 
preclinical evaluation of a pHEMA-co-AAm phosphorescent glucose sensor (Section 
3.3), chemically modified pHEMA copolymers and the physicochemical 
characterization thereof (Section 4.3), and hybrid materials to optimize oxygen transport 
(Section 5.3). Some of the results and associated methods presented in Chapter 3 were 
published in the Journal of Diabetes Science and Technology and in Chapter 4 were 
published in IEEE Sensors Proceedings. The results and associated methods presented in 
Chapter 5 have been submitted for publication. Finally, Chapter 6 presents the 
conclusions drawn from this work, and future directions are proposed. 
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2. BACKGROUND 
 
2.1. Traditional Materials in Continuous Monitoring Devices 
Research and development efforts in implantable device design involve making 
the device “biocompatible,” a term generally accepted as a device that encompasses 
materials that are not just cytocompatible (i.e., not cytotoxic) but that also retain 
biofunctionality of the device in the specific anatomical location where the device is 
applied [46]. This includes not only alleviating or mitigating the body’s response to the 
implant, but also eliciting the proper host response to maintain function of the device in 
its intended biological application [47]. 
In the realm of biosensing, the operational lifetime of a biosensor is an indicator 
of the stability of its sensing components in its intended environment and the device’s 
ability to transduce analyte signals over time. When considering biocompatibility of 
implantable biosensors specifically, the reported predominant biological events altering 
sensor functionality and preventing sustained device operational lifetime in vivo are (1) 
biofouling and (2) fibrosis. In both cases, signal attenuation and diminished signal 
reliability are fundamentally altered on the molecular level due to decreased substrate 
transport to the device. The following section provides a summary of the current state-
of-the-art of transcutaneous sensors and the polymeric materials used in these devices. 
2.1.1. Transcutaneous Sensors 
The oldest types of commercial continuous biochemistry monitors contain 
electrochemical sensors. These devices require an electrode that punctures the abdomen 
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and is connected to an external transmitter to convert electrical signals to analyte 
concentrations [15, 16, 19, 29, 48]. While wearable devices (e.g, step counters and heart 
rate monitors) have been adopted by many people into their everyday lifestyles, they do 
not directly measure actual blood biochemistry fluctuations, but rather externally 
measured physiological phenomena. However, perhaps the most ubiquitously used 
device for monitoring real-time biochemistry on a daily basis is the CGM, given the 
worldwide prevalence of diabetes. Various polymeric materials have been used to create 
films, gels, and other coatings for these electrodes to increase their biocompatibility in 
vivo [48]. Most commonly, these sensors have a membrane composed of polyurethane or 
a pyridine copolymer such as those used in the Medtronic MiniMed and Abbott 
FreeStyle Navigator commercial models, often entrapping GOx within the membrane by 
both chemical and physical means [49, 50].  
One completely non-invasive CGM, the GlucoWatch, became commercially 
available in the early 2000s. The GlucoWatch used reverse iontophoresis to attract ions 
to the electrode and subsequently bring interstitial fluid to the skin surface; it consisted 
of a hydrogel containing poly(ethylene glycol) (PEG) and poly(acrylic acid) containing 
GOx. The hydrogel served as a selectively permeable membrane allowing glucose, ions, 
water, and other small molecules to pass through to the device to produce peroxide and 
amperometrically determine glucose concentrations [51]. Despite the attractiveness of a 
completely non-invasive CGM, patient reports of severe rashes and blistering, as well as 
reports of highly unreliable glucose readings during times of intense exercise and 
perspiration, led to the removal of this device from the market in 2007 [52, 53].   
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The GlucoDay was created in Florence, Italy and combines amperometry with 
microdialysis [51]. GlucoDay contains a platinum electrode covered with three 
membranes: 1) cellulose acetate, 2) GOx, and 3) poly(carbonate) [51]. However, this 
electrode is external to the body and does not puncture the abdomen; this is currently the 
only CGM on the market that does not use an implanted sensor [53]. The GlucoDay 
extracts glucose via microdialysis and measures the effluent glucose concentration 
amperometrically. Because this device requires the patient to wear perfusion bags 
around the abdomen and the dialysis fiber must be replaced every 48 hours, the 
GlucoDay is limited to measuring blood glucose in clinical settings [51, 53].   
Fluorinated polymers and siloxanes have been used in CGM research due to their 
anti-fouling nature and high oxygen permeability, respectively [48]. Specifically, Nafion 
is a sulfonated tetrafluoroethylene that is known for its excellent electrical conductivity 
and resistance to biofouling. One study showed that heat curing Nafion on the outer 
surface of the electrode showed resistance to degradation and sensor sensitivity in dogs 
for 10 days in vivo [54]. Another fluoroethylene, Teflon, has been used as well in CGMs 
because of its anti-fouling nature. Specifically, Blubaugh and Brunsman developed a 
CGM electrode that uses a membrane with a semi-interpenetrating network (semi-IPN) 
morphology consisting of Teflon and poly(dimethylsiloxane) (PDMS) as a way to 
compensate for oxygen deficits and biofouling simultaneously in vivo  [55]. Certain 
merits of this design (i.e., selectively increasing oxygen permeability and using higher-
order architectures within the polymer matrix) serve as the inspiration behind certain 
matrix designs for fully implantable biosensors described in Chapters 5 and 6 of this 
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work. As a segue into using such polymer matrices (i.e., hydrogels) in fully implantable 
optical biosensors, an overview of optical assays used in hydrogels for implantable 
biosensors is presented in Section 2.2.   
2.2. Fully Implantable Biosensing Platforms 
Transitioning to a fully implantable sensing platform opens the door to utilizing 
classes of biomaterials and transduction assays in unique ways beyond those of 
transcutaneous electrochemical biosensors. Using materials that more closely resemble 
the physical and chemical properties of human skin may allow researchers to utilize 
unique material properties, refining sensor performance and device operational lifetime 
in vivo. 
Hydrogels are a class of biomaterials made of crosslinked polymer networks that 
swell in water without dissolving, allowing them to retain properties of solids [56-61]. 
Furthermore, hydrogels can have physical and chemical properties that match those of 
human skin, as well as other native tissues, and have been used in various biomedical 
device applications including contact lenses, microcantilevers (MEMS), drug delivery 
vehicles, prophylactic devices, and tissue engineering scaffolds [56, 57, 60-62]. 
Demonstrations of potential hydrogel sensor formats over the years have included PEG-
based microspheres and fibers and include a variety of hollow polymeric capsules and 
various nanocomposite particulate systems using other encapsulating materials [22, 24-
27, 63-65]. Utilizing these unique properties of hydrogels in a fully implantable CGM 
may circumvent repetitive tissue trauma and infection associated with the percutaneous 
nature of traditional CGM devices in vivo [17, 18, 66]. 
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Used in medical devices for decades, one of the most widely studied and well-
characterized hydrogels for biomedical applications is poly(2-hydroxyethyl 
methacrylate) (pHEMA) [58, 67]. Initially, pHEMA was primarily used in soft contact 
lenses, but it has also been exploited for a wide variety of biomedical applications 
including drug delivery, tissue engineering, drug delivery, and blood-contacting devices 
[58, 60, 61, 68-73]. Recent work has shown that pHEMA-based hydrogels can be 
functionalized with enzymes and phosphorescent dyes to be used as luminescence-based 
glucose sensors [24]. The same study illustrated the ability to tune sensor behavior by 
the composition of the hydrogels, which influences the glucose and oxygen diffusion 
rate. In vitro and in vivo biofouling of sensors was characterized, and the effects on 
substrate transport and overall sensor performance in vitro were determined for pHEMA, 
polyacrylamide (pAAm), and pHEMA-co-AAm copolymer hydrogels [24]. This study 
revealed that matrix chemistry can significantly impact the extent of biofouling on the 
matrix material, altering the diffusivity of glucose through the sensor and the sensor’s 
overall dynamic range and sensitivity, decreasing maximum sensitivity by up to 35%. 
Additionally, this work established serum exposure as a good predictor of in vivo 
biofouling behavior and that using serum exposure to predict biofouling and changes in 
glucose transport could accelerate the translation of this optical enzymatic glucose-
sensing platform to preclinical in vivo testing [24].  
Various methods have been investigated in recent years to transduce 
biochemistry levels in hydrogels by functionalizing them with optical assays. The 
following presents a brief summary of three approaches, focusing on glucose-sensing 
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assays due to the prevalence of diabetes worldwide, the abundance of glucose in the 
body as an analyte, and the fact that these two premises drive many researchers to use 
glucose as a proof-of-concept analyte when developing optical biosensors and a 
personalized healthcare monitor. Additionally, it is worth mentioning that the creation of 
a personalized health monitor for chronic disease management may require multiplexing 
two or more of these assays together. While this section delineates fundamentals of these 
three assays, the key principle is that using various non-interfering modalities will allow 
temporal, spectral, or other optical separation (e.g., fluorescence vs. Raman scattering) 
necessary to multiplex several assays together.   
2.2.1. Competitive Binding Assays 
One class of assays used for the purpose of continuous and on-demand 
biochemistry monitoring is a competitive binding assay. These assays contain a 
luminophore and quencher (i.e., quantum dots or a fluorescent dye), a binding ligand 
(e.g., dextran or another polysaccharide), and an analyte receptor (i.e., concanavalin A 
(ConA)) [63, 74-79]. Competitive binding affinity sensors offer the potential for long-
term, real-time sensing capabilities without reagent consumption or formation of harmful 
byproducts, such as hydrogen peroxide or acid, and are not affected by diffusional 
changes of any substrate besides glucose. They rely on energy transfer between optically 
tagged donor and acceptor components in order to transduce binding events, which can 
then be correlated to analyte concentrations. A commonly used affinity assay is the 
glucose assay based on a competitive binding scheme where saccharide receptors such 
as ConA bind to ligands (e.g., dextran or trimannose), competing with ConA for glucose 
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[64, 76, 79-86]. While sensitive Förster resonance energy transfer (FRET)–based 
glucose sensors have been developed, this assay is based on luminescence intensity 
measurements, and the signal level is highly affected by the light scattering milieu of the 
skin, which could complicate optical interrogation of the sensors [78]. Other factors 
plaguing the feasibility of many FRET assays include systems being excited by 
wavelengths of light that is highly absorbed or scattered by the skin (e.g., green light, 
blue light, etc.), spectral overlap of the two fluorophores, low molar absorbtivity, low 
quantum yield, small Stokes shifts, and photobleaching [87]. Recent efforts have 
developed chromophores that address some of the aforementioned drawbacks of optical 
probes used in FRET systems, including molecules excited in the near-infrared region. 
In particular, porphyrins have been emphasized as a class of organic chromophores 
having high photostability and large Stokes shifts [88]. These two properties make them 
attractive for optical biosensing and the eventual design of an implantable personal 
health monitor. Applications of these porphyrins in biosensing are described in detail in 
Section 2.2.2.       
2.2.2 Phosphorescence Lifetime Assays 
As an alternative to competitive binding assays, the McShane group has 
investigated biosensing platforms based on the coupling of oxidoreductase enzymes and 
oxygen-quenched phosphors (metalloporphyrin dyes) to detect glucose levels indirectly 
through detecting oxygen levels [22-24, 26-28, 34, 35]. One advantage of these assays 
over the previously mentioned competitive binding assays is that these dyes have 
luminescence lifetimes on the order of microseconds, rather than nanosecond lifetimes 
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characteristic of naturally occurring chromophores found in blood and proteins (e.g., 
heme groups) [89-91].  This means that the lifetimes of these metalloporphyrin dyes are 
temporally separate from those of native proteins, mitigating background signal due to 
skin autofluorescence when porphyrin emission light is collected after the time of 
fluorescence decay. Time-resolved measurements of phosphorescent lifetimes can be 
accomplished by using custom-designed hardware containing a pulsed light source and 
software consisting of algorithms that delay emission collection until the background 
fluorescence has decayed to zero [28, 65, 92-94]. Coupling oxygen-quenched phosphors 
with oxidoreductase enzymes such as GOx presents many advantages for long-term 
biosensing as there are numerous oxidoreductase enzymes commercially available, and 
enzymes are used throughout biomedical, biochemical, analytical chemistry, and various 
industrial fields due to their notorious specificity/selectivity for unique chemical 
substrates and their ability to catalyze chemical reactions involving those substrates with 
high efficiency [95]. Mathematical description of these porphyrin/enzyme diffusion-
reaction systems is found in Chapters 3 and 4. 
Despite their effectiveness as molecular catalysts, enzyme performance and 
functional longevity is often limited due to the strong influence of environmental 
conditions including pH, salt concentration, and temperature [96]. To improve 
performance stability, enzymes are often modified directly or immobilized in or on 
various structures to prolong their catalytic function [95-106]. In the case of immobilized 
enzymes, primary or secondary bonding with the immobilization substrate can cause 
steric hindrance or blockage of the enzyme’s active and/or deactivation. The 
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immobilized enzyme’s performance may decrease due to inability to chemically catalyze 
a reaction because of a physical constraint (confinement or blockage to enzyme’s active 
site). It is often difficult to determine the absolute activity of immobilized enzymes 
because changes in catalysis can be due to deactivation of the enzyme itself, physical 
constraint (steric hindrance), and/or increased diffusion barrier provided by the 
immobilization substrate (e.g., polymer films and hydrogels). 
Fortunately, GOx is one of the most versatile enzymes and is used in numerous 
biotechnology, nutritional, and consumer industries in applications ranging from 
bioreactors to biomedical devices and food/drink additives [101, 107]. Researchers have 
worked on immobilizing GOx on various substrates including polymer films, glass 
substrates, micro- and nanoparticles, and hydrogels [22, 95, 97, 99-101, 103, 105, 108-
115]. Numerous combinations of materials and immobilization strategies are used to 
incorporate enzymes into structures for various applications, including hydrogel matrices 
with phosphors to develop fully implantable biosensors [24, 28, 65]. Phosphorescence 
assays will be the focus of later chapters in this work. 
2.2.3 Plasmonic Assays Based on Surface-Enhanced Raman Spectroscopy 
While competitive binding assays and phosphorescence lifetime assays both offer 
advantages in transducing biomolecule levels in real time with high specificity, they both 
have disadvantages. Often, competitive binding and phosphorescence assays contain 
proteins that can denature or deactivate, causing the assay to lose its sensitivity or even 
its overall function. On the device level, loss in sensitivity translates to decreased signal 
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levels, resulting in frequent recalibration, decreased signal-to-noise ratio (SNR), and 
eventual sensor replacement. 
Plasmonic nanoparticles have gained interest in biosensing because of their 
potential to detect molecular binding events with high sensitivity and their ability to be 
excited at a particular wavelength without the risk of photobleaching like some of the 
fluorophores used in competitive binding assays [116, 117]. Metallic nanomaterials (i.e., 
gold and silver) have been exploited for this biosensing application by investigating 
optical phenomena such as localized surface plasmon resonance and surface-enhanced 
Raman spectroscopy (SERS) [116]. 
Specifically, SERS assays have been exploited in biosensor design because of 
their ability to increase Raman scattering intensity up to eight orders of magnitude 
versus traditional Raman scattering interactions. SERS substrates often consist of 
metallic nanoparticles made of bioinert metals such as gold or silver [117, 118]. SERS 
harnesses the power of surface plasmon resonance (SPR), which occurs in metallic 
structures at the nanoscale, to selectively interact with certain molecules and amplify 
Raman scattering signals. Although they do not provide the same type of temporal 
separation of luminescence lifetime as long-lifetime phosphors mentioned in Section 
2.2.2, their photostability, spectral tunability, and ability to be made from bioinert 
materials (i.e., gold) still render them attractive from a biosensing standpoint, especially 
when functionalized with moieties to selectively amplify signals of biomolecules via 
SERS [119]. 
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The Van Duyne group has made significant strides in establishing proof of 
concept of monitoring biomolecules with SERS substrates both in vitro and in vivo. In 
recent work from the Van Duyne group, nanoparticles (usually silica) are immobilized 
on a flat titanium substrate and coated with a silver or gold coating to impart Raman 
scattering ability to the particles; they are then functionalized with a self-assembled 
monolayer to impart selectivity to glucose [120, 121]. In fact, one study demonstrated 
that these materials, when planted subcutaneously in rats, can respond to glucose for 
over 17 days [121]. In comparison, commercially available CGMs only last up to seven 
days [16, 50, 122]. However, only 17 days of in vivo function for a fully implantable 
device is not ideal, as it is much more difficult to remove than current transcutaneous 
CGMs on the market. One factor hindering the long-term function of these implants (i.e., 
on the order of months) could be the interference of other biological molecules, such as 
proteins, with the glucose-sensitive ligand on the particles. Although the authors chose 
titanium as a substrate based on its FDA approval in other medical devices such as hip 
replacements, studies have shown that surface morphology can influence the 
inflammatory phenotype of immune cells and, ultimately, the severity of the FBR (i.e., 
fibrosis) [123, 124]. Presence of fibrosis could wall off the implant from the rest of the 
body, restricting bloodflow to the sensors and restricting access to glucose as described 
in other work with electrochemical glucose sensors containing metal components [125, 
126]. Immobilizing the SERS assay in or on an implantable substrate that better mimics 
the chemical and physical properties of subcutaneous tissue may extend the operational 
lifetime of subcutaneous SERS sensors in vivo.  
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Recently, SERS-based plasmonic assays have been encapsulated in hydrogels 
and have been shown to measure pH and glucose in real time. A response to glucose was 
shown by encapsulating GOx and mercaptobenzoic acid (MBA)–tagged gold 
nanoparticles, measuring gluconic acid production from GOx [127]. However, only 
benchtop proof of concept has been demonstrated with this system in a 96-well plate. 
Additionally, because the body is a buffered environment, time-delayed response is a 
prominent hurdle for these systems (governed by substrate diffusion and conversion of 
glucose to gluconic acid) because of the interaction of MBA with ions in the surrounding 
interstitial fluid. This implantable sensing platform shows potential for real-time 
monitoring of substrates for personalized healthcare, but is still in early developmental 
stages and has not been shown to rapidly transduce clinically relevant biomarkers (i.e., 
glucose) in real time in vivo. Refinement of the system design (hardware and glucose 
response time) must be accomplished before practical in vivo measurements can be 
made. For this purpose, the rest of this work will focus on phosphorescence lifetime 
assays due to the fully characterized figures of merit in previous work. 
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3. PRECLINICAL PERFORMANCE OF PHEMA COPOLYMER HYDROGELS AS 
GLUCOSE SENSORS* 
 
3.1. Introduction 
As discussed in Section 2.2.2, phosphorescence-based assays have been 
encapsulated inside various hydrogel materials, both synthetic and natural, for minimally 
invasive glucose monitoring [22, 24-27]. These sensor designs have consisted of 
nanofilm-coated alginate microspheres and injectable pHEMA-based discs both 
comprising green-excitable oxygen-quenched phosphors and, in some cases, an 
additional reference fluorophore [22-24, 26, 27]. Previously, hydrogel-based sensing 
platforms have been evaluated through various avenues: modeling, in vitro 
characterization, and implantation into rats to test ex vivo [24]. While these studies 
helped pave the way for in vivo proof of concept, one main hurdle to observing a 
successful real-time response to glucose is the green excitation of the PtOEP and 
PdTCPP phosphors, as green light is strongly absorbed by the skin [22, 26]. 
Biocompatibility of pHEMA-co-AAm copolymer gels has been studied in detail 
with green-excitable phosphors. Prior work investigated glucose transport properties of 
three gel formulations: pHEMA and pAAm homopolymer gels and a 50:50 
HEMA:AAm copolymer. These studies investigated the effect of adding matrix 
                                                 
* Parts of this section are reprinted with permission from R. M. Unruh, J. R. Roberts, S. P. Nichols, S. 
Gamsey, N. A. Wisniewski, and M. J. McShane, "Preclinical Evaluation of Poly(HEMA-co-acrylamide) 
Hydrogels Encapsulating Glucose Oxidase and Palladium Benzoporphyrin as Fully Implantable Glucose 
Sensors," Journal of Diabetes Science and Technology, vol. 9, no. 5, pp. 985-992, 2015. Copyright © 
2015 by SAGE Publishing Inc. Reprinted by permission of SAGE Publications. 
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chemistry on glucose transport as well as impacts of in vitro biofouling (exposure to rat 
serum) and in vivo implantation on sensor response over a one-month time period. This 
study found that adding pAAm to the pHEMA gels increased glucose transport over 30-
fold (regardless of 50 or 100% AAm), translating to a 496% increase in maximum 
sensitivity. However, while both the pHEMA homopolymer and the 50:50 HEMA:AAm 
were found to have lower limits of detection well in the hypoglycemic range (4.2 and 
17.6 mg/dL for pHEMA and p(HEMA-co-AAm), respectively), a 286 mg/dL decrease in 
the upper limit of detection was observed with the 50:50 HEMA:AAm compared to the 
pHEMA homopoymer, rendering the upper limit of detection at only 70.5 mg/dL for 
50:50 HEMA:AAm versus 356 mg/dL for the pHEMA homopolymer. In other words, 
the 50:50 HEMA:AAm sensor’s dynamic range was confined to detect only 
hypoglycemic levels and could not detect euglycemic or hyperglycemic levels, whereas 
the dynamic range of the pHEMA sensors encompassed the hypo-, eu-, and 
hyperglycemic ranges. Stable signal levels could not be established with 100% 
acrylamide (AAm) hydrogel sensors, and these sensors were not tested for optical 
response to glucose. This suggests that some HEMA content could be necessary to 
ensure sensor stability, even though experiments showed that more HEMA results in 
decreased sensitivity to glucose. 
Interestingly, serum exposure experiments indicated that all three formulations 
showed a significant (t-test, α = 0.05) drop in glucose permeability after one week of 
serum exposure or one week of implantation, but little change in glucose diffusivity was 
observed from one week to one month of exposure or implantation, indicating that acute 
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nonspecific protein adsorption accounts for most of the changes in analyte permeability 
through these devices (as opposed to severe analyte occlusion), despite long-term 
fibrotic encapsulation. Although glucose diffusion experiments reported analyte 
accessibility to the sensor after one month of implantation, glucose sensors were not 
transdermally interrogated in vivo, and the rats were not challenged with glucose in order 
to measure real-time response to glucose [24]. 
The present work aimed to (1) extend the operating wavelength range for in vivo  
Figure 3-1: Illustration of transdermal optical interrogation of a subcutaneous sensor 
implant; left illustrates illumination, right illustrates implant emission. Image is only 
for understanding of system, and does not represent actual beam shape. Adapted with 
permission from SAGE Publications. © 2015 by SAGE Publications. 
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use by incorporating an alternative long-lifetime phosphor (Figure 3-1); (2) further 
characterize the in vitro glucose response characteristics of similar pHEMA-co-AAm 
hydrogels to more fully understand how to adjust their response properties to achieve an 
upper limit of detection in the hyperglycemic range without sacrificing sensitivity; and 
(3) perform proof-of-concept in vivo testing to evaluate its potential for use as 
implantable biosensors by tracking rising and falling glucose levels in real time. 
This approach includes replacing the aforementioned phenyl porphyrin dyes with a 
benzoporphyrin dye. The literature has highlighted the potential of similar 
benzoporphyrin dyes—modified with moieties such as sulfonate groups and PEG chains, 
complexed with other metals such as Pt(II) and Zn(II), and encapsulated in various 
materials such as poly(styrene-block-pyrrolidone) and poly(sulfone)—as nanobeads to 
monitor subcutaneous tissue oxygen levels due to their NIR emission wavelength [90, 
91]. These studies demonstrated several variations of benzoporphyrins with Q-bands 
near 630 nm and quantum yields 16 to 18% higher (in dimethylformamide, DMF) than 
the PdTCPP dyes used in previous green-excitable glucose sensors, suggesting that 
glucose sensors made with Pd(II) benzoporphyrins could be brighter and have a higher 
SNR than the same sensor made with PdTCPP [65, 90]. In addition, the highest-reported 
natural lifetime, τ0, of these benzoporphyrins is 363 µs (room temperature, encapsulated 
in polystyrene) [91], whereas lifetimes for PdTCPP over 600 µs have been reported in 
pHEMA hydrogels [24]. This means that while the benzoporphyrins may better suited 
for in vivo transdermal optical interrogation (red excitation and higher quantum yield), 
the absolute microsecond resolution for a given change in oxygen concentrations will be 
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less than for PdTCPP, making a glucose sensor in pHEMA-based materials less sensitive 
than the equivalent sensor made with the PdTCPP phosphor. 
In the present work, glucose sensors were synthesized with tetramethacrylated 
Pd(II) benzoporphyrin (PdBP) phosphors. Sensor behavior was investigated in various 
pHEMA-co-AAm formulations, allowing the dye to act as a covalently attached four-
arm crosslinker in the matrix (Figure 3-2).  In addition, solubility of the sensing assay 
was investigated. Finally and importantly, this work demonstrates the first successful 
transdermal optical interrogation and glucose challenge in a porcine model. 
  
Figure 3-2: Structure and excitation/emission spectra of the 
PdBP dye 
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3.2. Theory and Methods 
It is noteworthy that the benzoporphyrin dyes are oxygen-quenched; thus, 
in this enzyme-porphyrin platform, sensor response depends on the rate of glucose and 
oxygen consumption by GOx and the extent of local oxygen depletion near the dye. 
Hence, sensor response depends on the availability of the substrates glucose and oxygen 
to the enzyme (governed by mass transport), as well as the affinity of the enzyme for 
both substrates [22-24, 26-28]. 
Luminescence lifetimes of the benzoporphyrin dye in these sensors depend on 
the local oxygen concentration around the dye, governed by oxygen flux into the sensor. 
The Stern-Volmer relationship illustrates the behavior of collisional quenching of dye 
phosphorescence by oxygen which can be related to the diffusion kinetics underlying the 
glucose response according to the Stern-Volmer quenching relationship, illustrated by 
the following equation  [90, 91, 128]. 
𝜏0
𝜏 =  
𝐼0
𝐼⁄ = 1 +  𝐾𝑆𝑉[𝑂2]
⁄  
In the above relationship, 𝜏0 and I0 are the luminescence lifetime and intensity in 
the absence of oxygen, respectively; 𝜏 and I are the luminescence lifetime and intensity 
at a particular oxygen concentration, [𝑂2]; and  𝐾𝑆𝑉 is the Stern-Volmer constant 
representing the linear relationship between the ratio 𝜏0 𝜏⁄  and [𝑂2]. 
The following experimental methods have been designed to characterize more 
fully pHEMA-co-AAm glucose sensors from the standpoint of sensor homogeneity, 
underlying oxygen response, and overall glucose response. Figures of merit are obtained 
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from in vitro experiments and pave the way for more robust sensor preparation for 
preclinical evaluation, in vivo transdermal optical interrogation, and real-time tracking of 
blood glucose. 
Firstly, three pHEMA-co-AAm formulations were fabricated with GOx and the 
PdBP phosphor. These formulations were investigated qualitatively for homogeneity and 
solubility of the sensing chemistry. Additionally, the gels were subjected to a screening 
test, where the thermostability of GOx was evaluated over a two-week period as a first-
pass test for sensor functionality and stability. Results from the screening were 
reconciled with the observations of homogeneity in order to lay the groundwork for 
refining the sensor formulation. 
Secondly, in vitro sensor response was investigated to observe real-time response 
of the sensors to both oxygen and glucose. Data were collected for both Stern-Volmer 
oxygen-quenching kinetics and optical response to glucose at ambient oxygen 
concentration in order to determine how the glucose response relates to the underlying 
oxygen response. Steady-state response plateaus at each oxygen concentration were used 
to generate Stern-Volmer quenching plots and a glucose calibration curve (a plot of 
steady-state lifetime versus glucose concentration). Stern-Volmer constants (Ksv) and 
bimolecular quenching constants (kq) were calculated from the oxygen diffusion data 
and compared to previously reported immobilized benzoporphyrins. Similarly, glucose 
calibration curves were used to determine the analytical range and sensitivity of sensors 
and allow a method to compare this red-excitable platform with previously-used green-
excitable sensing platforms. 
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Finally, the sensors were injected into a porcine model to investigate preliminary 
preclinical performance of this benzoporphyrin-based sensing platform. While previous 
studies indicated promising biocompatibility in rats based on the extent of biofouling 
and its effect on glucose transport through the sensor matrix, the sensors were neither 
interrogated transdermally nor tracked during a glucose challenge. The experiments in 
this chapter introduce three major advances from previous in vivo studies: (1) fabricating 
benzoporphyrin sensors as injectable strips for evaluation in porcine models, (2) 
interrogating the sensors and measuring phosphorescence lifetime transdermally using a 
portable red-excitation luminescence lifetime hardware system, and (3) monitoring 
sensor response in real-time to rising and falling glucose levels in vivo. 
3.2.1. Materials 
Tetraethylene glycol dimethacrylate (TEGDMA) and 2-hydroxyethyl 
methacrylate (HEMA, ophthalmic grade) and were purchased from Polysciences, Inc. 
(Warrington, PA). Ethylene glycol, 2,2-dimethoxy-2-phenyl-acetophenone (DMPAP), 1-
Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC), sterile phosphate-
buffered saline (PBS, 0.01M phosphate buffer, 0.154M sodium chloride), o-dianisidine, 
horseradish peroxidase, and catalase (CAT) were obtained from Sigma-Aldrich® (St. 
Louis, MO). GOx was obtained from BBI™ Solutions (Cardiff, UK). Sodium chloride, 
potassium chloride, potassium phosphate (dibasic), sulfo-N-hydroxysuccinimide (sulfo-
NHS), and dimethyl sulfoxide (DMSO) were purchased from VWR® (Radnor, PA). 
Sodium phosphate (monobasic) and glucose were purchased from ACROS Organics 
(ThermoFisher Scientific Inc., Waltham, MA) and Macron Fine Chemicals™ 
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(Avantor™ Performance Materials, Inc., Center Valley, PA), respectively. Acrylamide 
and sterile DI water were purchased from AMRESCO® (Solon, OH) and Invitrogen™ 
(Life Technologies™, Grand Island, NY), respectively. Sterile 50% (w/w) dextrose was 
obtained from Cardinal Health (Dublin, OH). The red-excitable luminescent dye, a 
methacrylated PdBP (Figure 3-2), was custom-synthesized and donated by PROFUSA, 
Inc. (San Francisco, CA). The UV Lamp (Blak-Ray B-100SP) was purchased from 
UVP, LLC (Upland, CA). 
3.2.2. Hydrogel-Based Glucose Sensor Fabrication 
Three formulations were chosen to investigate based on prior work: a pHEMA 
homopolymer, a 75:25 HEMA:AAm copolymer, and a 50:50 HEMA:AAm copolymer 
[24]. Hydrogels for injection were fabricated similarly as described previously [24] with 
a few changes (exchanging the green-excitable phenyl porphyrin with the red-excitable 
PdBP, Figure 3-2). 
 Screening by Glucose Oxidase Activity Assays 
To evaluate the feasibility of the formulations to house the sensing chemistry for 
the biosensing platform, gels of different compositions were evaluated for enzyme 
activity and stability with pure HEMA and AAm (40.2 w/w% in DI water). Gels of 
pHEMA (no AAm), 75:25 HEMA:AAm, and 50:50 HEMA:AAm were fabricated. To 
fabricate the hydrogels, the photoinitiator DMPA (2.5 mg) was weighed in a 2 mL 
microcentrifuge tube, to which was added 250 µL of the monomer(s) (appropriate v/v% 
ratio of AAm solution and HEMA), 5 µL of TEGDMA crosslinker, 90 µL of ethylene 
glycol, and 50 µL of a 10 mM PdBP solution in DMSO (or 50 µL of pure DMSO for 
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screening gels without dye) were added and mixed by vortexing. The enzyme 
component (107.5 µL in PBS) was added and mixed via pipette to avoid enzyme 
denaturation or deactivation from the shear force of vortexing. Gels with GOx only (2.3 
µM in PBS, pure DMSO), as well as with GOx and the PdBP dye (2.3 µM GOx in PBS, 
10 mM PdBP in DMSO) were prepared. 
It is worth noting that the GOx concentration (2.3 µM or 0.4 mg/mL in PBS) is 
100 times less than the GOx concentration used in glucose sensor implants [24, 65]. This 
was done due to the small volume of the assay cocktail used in each well of the well 
plate (200 µL), as well as the static test nature of the assay. In other words, the gel discs 
were exposed to a stagnant fluid for the duration of the experiment (due to the nature of 
the well plate structure) as opposed to the continuous flow experienced by the sensors 
when immobilized in the sample chamber, described in Section 3.2.3.2. 
When the sensors are immersed in a small volume of stagnant fluid in the well, 
the substrate levels are not replenished in the same manner as in a continuous flow 
system. Therefore, it is necessary to avoid saturating the assay (i.e., depleting one or 
more substrates necessary to catalyze the assay reaction); this will result in a rapid 
increase in absorbance signal change and then a distinct plateau due to insufficient 
substrate levels to transduce a subsequent absorbance signal change. Ideally, the enzyme 
level should be high enough to provide a sensitive absorbance change over the 
experimental time window (i.e., 30 minutes), but low enough so that the enzyme can be 
saturated by the substrates and operate at its maximum velocity throughout the duration 
of the experiment (i.e., saturating the enzyme versus saturating the assay). 
 31 
 
Gels with the full concentration of the enzyme (232.5 µM or 40.0 mg/mL) were 
found to saturate the assay within a matter of a few seconds; no change in absorbance 
could be observed in the plate reader due to nearly instantaneous depletion of the 
dissolved oxygen in the reaction cocktail.  A 100× dilution of GOx from standard levels 
(denoted in Chapter 3) allowed the enzyme to operate at Vmax throughout the duration of 
the screening experiments while transducing a distinct change in absorbance by o-
dianisidine at 495 nm (Figure 3-3). 
Precursor solutions were injected via syringes fitted with 26-gauge needles into 
glass molds with 0.01-in.-thick Teflon spacers secured with clips. Gels were 
photopolymerized with UV light (365 nm, 140 watts, three minutes per side). The  
 
Figure 3-3: Illustration of the coupled redox reactions involved in the glucose 
oxidase activity assay. The first reaction (top) involves the oxidation of glucose into 
glucono-δ-lactone (quickly hydrolyzed into gluconic acid in aqueous environments), 
catalyzed by GOx, producing hydrogen peroxide. The second reaction (bottom) 
illustrates the reduction of hydrogen peroxide and the oxidation of o-dianisidine, 
inducing a visual color change in solution from colorless to burnt orange. 
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resulting crosslinked gels were removed from the mold, rinsed with DI water, and placed 
in 40 mL PBS with 0.056 mg EDC and 0.16 mg sulfo-NHS to crosslink enzymes and 
prevent enzyme leaching. After equilibration in PBS, 5-mm-diameter hydrogel discs 
were punched with a biopsy punch (for the purpose of lining a 96-well plate to perform 
the activity assays) and were placed in fresh PBS in a 15 mL centrifuge tube. The tubes 
were placed in an incubator at 37 °C in PBS for two weeks. The apparent activity of the 
GOx-only gels were tested initially and weekly after incubation using a colorimetric o-
dianisidine absorbance-based activity assay, measuring absorbance at 492 nm versus 
time [129]. Activity measurements were also performed on GOx dissolved in phosphate 
buffer (pH 7.4) and were stored under the same conditions for comparison. 
 Injectable Glucose Sensor Fabrication 
For implantation, a different hydrogel shape was chosen: 5-mm-long strips with a 
~750 µm × 750 µm square cross section). This shape was selected for ease of insertion 
through a needle. The enzyme component in PBS contained 232.5 µM GOx and 25 µM 
CAT; CAT acts as a peroxide scavenger that aids in preserving GOx activity. The PdBP 
was dissolved in DMSO at a concentration of 10 mM  (1 mM in the final gel). 
Precursors containing the enzymes and PdBP dye were injected into glass slide 
molds, each with a 0.03-in.-thick Teflon spacer secured with clips. Gels were 
photopolymerized with UV light (365 nm, 140 watts, three minutes per side). Finally, 
the gels were removed from the mold, rinsed with deionized water, and placed in 40 mL 
of PBS with 5.6 mg of EDC and 16 mg of sulfo-NHS and were allowed to equilibrate in 
this solution overnight to crosslink enzymes and prevent enzyme leaching. Oxygen-
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sensitive reference sensors (O2 Ref) were fabricated with the same parameters as 
described, except PBS replaced the enzyme solution and strips were not exposed to 
EDC/NHS. Materials for injection were cut to the same final dimensions described 
above. 
3.2.3. In Vitro Sensor Response 
 Lifetime Measurements: Optical Interrogation and Data Collection 
Sensors were monitored with a custom luminescent measurement system through 
a LabVIEW interface. The measurement system uses LEDs (Philips Lumileds Luxeon 
Rebel Red λex = 630 nm) driven at ~200 mA (typical) for ~40 mW output during ON 
cycles. LEDs are typically pulsed ON for 250 µs and then held OFF for 5000 µs while 
the emission decay is monitored. Emission intensity is monitored with silicon PMTs 
(SensL) after collecting emission through a lens and filter (λem = 809 ± 40 nm, Semrock). 
The excitation source (LED) and detector (silicon photomultiplier) are housed in a 1.5-
in. diameter puck where the 1 mm apertures for the excitation and emission are spaced at 
6 mm. The puck is placed in contact with the flow cell (in vitro) or animal skin (in vivo). 
Emission decay curves are processed using nonlinear least-squares regression 
(Levenburg-Marquardt algorithm) using a mono-exponential decay to calculate the 
lifetime (τ) and intensity of the long-lived component (phosphorescence); the baseline 
background intensity resulting from scattered excitation light bleeding through the filter 
is then calculated as the residual of the difference between the fitted curve and the actual 
decay. In this experiment, the instrument was configured to measure the luminescent 
lifetime on each channel once every five seconds. Due to limited implantation space, 
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three sensors were monitored simultaneously in both the in vitro and in vivo 
experiments. Limited implantation space arose from testing these glucose sensors in 
parallel with other sensor formulations, including controls, standards, and shams. Some 
of those sensors were used in this study (controls), but others were used in separate 
experiments conducted by PROFUSA, Inc. which are not detailed in this work. 
 Glucose Response 
To test the in vitro optical response of the sensors to glucose, sensor strips were 
immobilized in a sample chamber adapted from a previously described glucose flow-
through apparatus (Figure 3-4) [24]. Briefly, two reservoirs (one containing PBS and the 
other containing 400 mg/dL glucose in PBS) were connected to two separate pumps 
controlled by a LabVIEW program. Combined pump effluents flowed directly to the 
sample chamber housing the immobilized sensing strips. The sample chamber consisted 
of a Teflon spacer with slots for samples to lie, housed between an acrylic base and top 
plate and secured with screws in an acrylic top plate.  Chamber effluent drained directly 
into a waste tank. During the glucose experiment, sensors were exposed to six 
Figure 3-4: In vitro glucose response benchtop testing system 
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concentrations of glucose (0, 50, 100, 200, 300, and 400 mg/dL) in an incubator at 37 
°C. These parameters were chosen based on relevant physiological concentrations of 
blood glucose and physiological temperature. After the final glucose concentration was 
reached (400 mg/dL), PBS (0 mg/dL glucose) was flowed over the sensors to test sensor 
reversibility. 
Raw data (phosphorescent lifetime and timepoints) were plotted in MATLAB to 
generate a step response curve (lifetime versus time). To calculate the sensor calibration 
curves, 10 data points in each steady-state response region were averaged and their 
standard deviations calculated. The average and standard deviations in steady-state 
responses for each glucose concentration tested were plotted against the glucose 
concentrations to calculate dynamic range and sensitivity. The dynamic range and linear 
sensitivity of the sensor implants were calculated by fitting a curve to the data using a 
nonlinear least squares regression method. The upper and lower limits of detection were 
calculated using the 3σ approach: the lower limit was defined as the baseline lifetime 
plus three times the standard deviation, whereas the upper limit was defined as the 
saturation lifetime minus three times the standard deviation. The linear sensitivity was 
calculated as the slope of the line connecting the upper and lower limits of the analytical 
range. 
 Oxygen Response 
For oxygen diffusion experiments, a similar setup was used, except a single 
recirculating system containing PBS was used (Figure 3-5). Mass flow controllers 
purged the PBS with nitrogen gas to vary oxygen levels, monitored with a calibrated 
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picoammeter (Unisense, Denmark). In both oxygen and glucose experiments, three strips 
were run simultaneously, and their luminescence lifetime responses to various glucose or 
oxygen concentrations were measured with the custom optical interrogation unit. For the 
oxygen diffusion experiment, sensors were exposed to five concentrations of oxygen in 
the physiological oxygen range: 50.22, 40.17, 30.13, 20.09, and 0 µM. The 
luminescence lifetime ratios were calculated and plotted against oxygen concentrations  
according to the Stern-Volmer equation in Section 0. Data were fit with a linear curve 
(R2 > 0.99) to determine the Stern-Volmer quenching constant. 
  
Figure 3-5: Stern-Volmer oxygen diffusion benchtop apparatus 
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3.2.4. In Vivo Sample Preparation 
All utensils were autoclaved prior to use. Glucose sensing hydrogel slab strips 
(~0.75 × 0.75 × 5 mm) were suspended in 70% ethanol in a sterile 50 mL centrifuge tube 
for 10 minutes in a biosafety cabinet. One-third of the total volume was poured into a 
waste beaker and replaced with sterile DI water three times, allowing the sensors to 
equilibrate for 30 minutes between each solvent exchange.  This gradual equilibration 
process was repeated but by (1) pouring off one-half of the total ethanol/water solution 
volume three times and filling with water, (2) pouring off the entire volume three times 
and filling with water, and (3) filling the entire tube with sterile PBS to equilibrate 
overnight prior to in vivo insertion. 
3.2.5. In Vivo Injection 
The animal protocol used in this study was approved by an IACUC committee at 
Texas A&M University. A female Sinclair mini-pig was obtained from Sinclair Bio-
Resources (Columbia, MO). The pig was initially anesthetized with an injection of 
telazol (5 mg/kg) and buprenorphine (0.01 mg/kg). The pig was sedated, intubated, and 
anesthetized, and then dorsal hair was shaved and skin was thoroughly cleaned. 
Anesthesia was maintained with 1.5 to 2.0% isoflurane (v/v in O2) to effect during 
sensor injections and blood glucose modulation. Skin was prepared for injections by 
scrubbing with ChloraPrep applicators (CareFusion, San Diego, CA).  Sensors were 
injected subcutaneously into the dorsum of the pig (42.0 kg, one year old) from an 18-
gauge cannula with a reverse-action plunger. 
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3.2.6. Glucose Challenge 
The blood glucose of the pig was modulated between 40 and 235 mg/dL via 
continuous intravenous (IV) infusion of 20% dextrose in sterile saline (diluted from 
sterile 50% dextrose), followed by IV bolus infusions of Humalog insulin (Eli Lilly, 
Indianapolis, IN) (Figure 3-6). Sensors were optically interrogated transdermally and 
non-invasively with the same external optical reader puck described previously. 
Luminescence lifetimes were recorded for two glucose-sensitive implants, an oxygen-
sensitive (but glucose-insensitive) reference implant, and a reference implant insensitive 
to both oxygen and glucose. The glucose- and oxygen-insensitive reference was  
Figure 3-6: Glucose infusion profile versus measured blood glucose values. Dashed 
red lines serve as visual guides and do not necessarily convey mathematical trends 
between data points. 
 
 39 
 
fabricated by encapsulating gadolinium-gallium-garnet crystals (GGG) in a pHEMA 
matrix. Capillary blood glucose was measured every 5 to 10 minutes in triplicate with 
three separate Accu-Check Nano glucometers (Roche, Indianapolis, IN). 
3.3. Results and Discussion 
3.3.1. Hydrogel Screening and Material Selection 
Previous studies with similar glucose-sensitive hydrogel materials focused on 
evaluating the effects of serum proteins and in vivo biofouling on glucose diffusion 
through the materials and corresponding sensor response characteristics [24]. Their 
results showed that the change in glucose diffusivity from one week to one month is 
lowest among materials containing AAm That is, biofouling seems to have the least 
influence on the sensors made with AAm. Therefore, pHEMA-co-AAm copolymers 
could be promising for developing a stable and accurate long-term, fully implantable 
CGM system, which sparked the rationale for using a pHEMA-co-AAm copolymer for 
the present study. It was hypothesized that adding AAm to the precursor formulation 
would increase the hydrophilicity of the precursor solution and water content in the 
polymerized hydrogel (after PBS equilibration), yielding better  
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water content in the polymerized hydrogel (after PBS equilibration), yielding better 
Figure 3-7: Photographs show the solubility of both sensing chemistry components—
the GOx enzyme and PdBP dye—in all three hydrogel precursor formulations 
investigated in this study. Images reveal that an intermediate concentration of 
acrylamide provides a common middle ground for both sensing chemistry components. 
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enzyme dispersion throughout the precursor solution and improving thermostability by 
the polymerized matrix. Interestingly though, incubation of the 50:50 copolymer blend at 
37 °C resulted in a statistically significant (t-test, α = 0.05) decrease in apparent activity 
after one and two weeks (Figure 3-7, top), whereas the enzyme activity of the pure 
pHEMA and the 75:25 copolymer did not significantly change over time. It is known 
that pAAm gels swell more in water than pHEMA gels [130-132]; for this reason, 50:50 
HEMA:AAm may have induced more strain on the enzyme due to swelling rather than 
protecting its native conformation and preserving activity. It should be noted that sensors 
were incubated in only PBS between in vitro tests to exclusively examine the 
thermostability of the GOx in the hydrogel matrix. Due to the consumptive nature and 
production of hydrogen peroxide by the GOx enzyme within the hydrogels, glucose was 
not added to incubating sensors. 
3.3.2. In Vitro Performance 
Based on the findings from the screening experiments and prior work, the 75:25 
HEMA:AAm hydrogels were chosen for further investigation as a host matrix for this 
sensing platform [24]. Highly sensitive responses were observed for the glucose range of 
0 to 200 mg/dL, as evidenced by the distinct stair-step curve in the raw data during the 
first four hours of the experiment (Figure 3-8, left). Sensors were exposed to each 
concentration for one hour and reached a steady-state response (lifetime plateau) within 
20 minutes. Overall, at 0 mg/dL and 50 mg/dL glucose, all three sensor response curves 
appeared very smooth and trended closely with one another with some slight, but 
negligible, difference in the steady-state response lifetime at 50 mg/dL.  More disparity 
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among the sensors’ steady-state response lifetimes is noticeable in the range of 100 to 
400 mg/dL glucose. This disparity may result from slight inhomogeneities in gels, as 
well as variations in sensor strip widths due to manual cutting procedures. These 
different surface-area-to-volume ratios as well as diffusion kinetics ultimately arrive at a 
different diffusion-reaction balance and, hence, different steady-state lifetimes [22]. 
Sensors were determined to have a dynamic range of 12 to 167 mg/dL with a linearized 
sensitivity of 1.44 ± 0.46 µs/(mg/dL). At the upper limit of the dynamic range, the 
lifetime of all three sensors was below the natural lifetime of the PdBP dye in this matrix 
(260.1 ± 4.3 µs) determined from Stern-Volmer experiments (Figure 3-8, inset). This 
suggests that the upper limit of detection is reached because of flux limitations of the 
substrates glucose and oxygen rather than complete consumption of oxygen throughout  
Figure 3-8: (Left) Response of the 75:25 HEMA:AAm copolymer to various glucose 
concentrations. (Right) Steady-state calibration curves for the 75:25 HEMA:AAm 
copolymer formulation (n=3, error bars represent 95% confidence intervals). Inset on 
right graph shows Stern-Volmer oxygen diffusion kinetics underlying the overall 
glucose response (n=3, error bars represent 95% confidence intervals). Reprinted with 
permission from SAGE Publications. © 2015 by SAGE Publications.  
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the entire sensor matrix. In other words, while both substrates are being consumed by 
GOx, the reaction may not be occurring throughout the entire volume of the sensor, but 
rather is being limited to the sensor surface due to the rate of substrate replenishment via 
diffusion into the sensor and the concentration of GOx in the sensor. If the rate of 
glucose replenishment at the site of the reaction is too high relative to that of oxygen, 
continued influx of glucose will not result in any further signal change. The system 
could be in an oxygen-limited state, despite the possibility of oxygen residing in deeper 
regions of the bulk matrix, resulting in a saturated sensor response before the natural 
lifetime of the dye is reached.  In fact, wider dynamic ranges have been reported in 
hydrogels with greater pHEMA content when using similar sensing chemistry, further 
supporting this claim [24]. 
After exposure to all of the glucose concentrations (50 to 400 mg/dL), the 
sensors were again exposed to 0 mg/dL glucose (Figure 3-8). The consistent lifetime 
measurements at 0 mg/dL before (28.7 ± 0.9 µs) and after exposure to various glucose 
concentrations (27.9 ± 0.9 µs) prove the full reversibility of the sensing system. 
3.3.3. In Vivo Performance 
Three glucose-sensitive implants were injected into porcine dorsal subcutaneous 
tissue, and two were successfully located and interrogated transdermally two hours after 
implantation with the same optical system used for in vitro analysis (Section 3.2.3). 
During the glucose challenge, the oxygen-sensitive control (O2 Ref) and the oxygen-
insensitive reference (GGG Ref) implants showed no response to changes in blood 
glucose levels (Figure 3-9). A drift downward in the O2 Ref lifetime was observed  
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throughout the experiment, which is believed to be the result of slow tissue re-
oxygenation following a test under hypoxic conditions that was conducted immediately 
preceding the glucose challenge. The downward-sloping lifetime trend observed during 
the experiment is likely due to local temperature changes around the sensor due to the 
electronic puck slightly warming the skin (Figure 3-10).  
This downward trend was observed with both oxygen sensors and glucose 
sensors. The collisional quenching of porphyrins by oxygen is described by the 
bimolecular quenching coefficient, 𝑘𝑞, by the following relationship 
𝑘𝑞 =
(4𝑟𝜋𝑅𝐷𝑁)
103
⁄  
where 𝑟 is the quenching efficiency (assumed to be 1), 𝑅 is the radius of interaction 
between PdBP and oxygen, 𝐷 is the sum of the diffusion coefficients of both PdPB and 
oxygen, and 𝑁 is Avogadro’s number [133]. Because PdBP is immobilized in the 
hydrogel and all other terms are constant in this application, the only term affecting the  
Figure 3-9: In vivo responses of subcutaneous sensor implants in the dorsum of a 
female Sinclair pigs. (Left) Sensor responses 2.5 hours (0 days) after implantation. 
Adapted with permission from SAGE Publications. © 2015 by SAGE Publications. 
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value of 𝑘𝑞 is the diffusion coefficient of oxygen.  Further, the diffusion of oxygen is 
governed by Brownian motion, described by the Stokes-Einstein equation  
𝐷 =  
𝑘𝐵𝑇
6𝜋𝜂𝑑ℎ
⁄  
where 𝐷 is the diffusion coefficient of oxygen, 𝑘𝐵 is Boltzmann’s constant, 𝑇 is the 
absolute temperature, 𝜂 is the solvent viscosity, and 𝑑ℎ is the hydrodynamic diameter of 
the Brownian particle (oxygen).  
 Because changes in the solvent viscosity, hydrodynamic diameter of oxygen are 
infinitesimally small with the temperature changes observed in this experiment, it can be 
said that 𝐷 is directly proportional to 𝑇, and 𝑘𝑞 is directly proportional to 𝐷. Therefore, 
Figure 3-10: Temperature fluctuations for all four reported in vivo sensors as 
measured by the electronic puck readers during in vivo glucose modulation. 
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the change in 𝑘𝑞 is directly proportional to the change in 𝑇. Based on experimental data 
provided by Sinaasappel and Ince, 𝑘𝑞 increases linearly with increasing temperature, as  
expected from the previous equations [134]. Using this experimental data, a 
proportionality constant relating 𝑘𝑞 and 𝑇 was calculated to be 5.71× 10
-6 μM-1-K-1 and 
was used to predict the change in 𝑘𝑞 based on the change in temperature observed in the 
in vivo experiment (from 30 °C to 37 °C, Figure 3-10). Using this model, a predicted 
lifetime decrease of 84 µs was calculated for the 7 °C increase in temperature; however, 
a lifetime decrease of only 25 µs was observed. The discrepancy between predicted and 
observed lifetime decreases can be attributed to using experimental data for PdTCPP to 
calculate the proportionality constant between 𝑘𝑞 and 𝑇. It is recommended that 
temperature calibration experiments be conducted to develop a more accurate model to 
predict the change in lifetime with fluctuating in vivo temperatures. Nevertheless, the 
mathematical equations and experimental data for PdTCPP agree that the effect of 
temperature on lifetime arises from a change in the quenching kinetics, governed by 
Brownian motion, for a given oxygen concentration. 
Focusing specifically on the response to glucose, the two glucose-sensitive 
implants tracked closely with measured blood glucose levels. The peak lifetime was 
around 200 µs, which is similar to the saturation lifetime seen during the in vitro glucose 
challenge. Additionally, these in vivo lifetimes and measured blood glucose values 
follow closely with observed trends in vitro based on the calibration curve data. 
However, the lifetime curves did not appear to reach a plateau despite the glucose levels 
rising above the in vitro saturation concentration of 200 mg/dL. The extended analytical 
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range suggests that the subcutaneous sensors did not experience the exact same glucose 
concentration as was present in blood. Many factors may influence the different behavior 
observed in vivo, including glucose consumption by inflammatory cells during the acute 
immune response window [135]. Since in this study the sensors were monitored only 
two hours after implantation, the difference seen here is most likely due to the slower 
diffusion of glucose in vivo in the short time following the insertion wound and the 
consumptive nature of the sensors [136, 137].  
 Finally, the different apparent response rate/lag time of the two glucose sensors is 
attributed to differences in anatomical sensor placement on the pig dorsum, the 
positioning of the pig during the procedure, and potentially different degrees of tissue 
trauma caused by sensor insertion. Although sensor-to-sensor variations observed in 
vitro could theoretically affect the in vivo response, in vitro variability was primarily 
manifested in different steady-state lifetimes, not response times (i.e., lag time or time to 
reach steady-state). Since sensor response variations seen in vivo are exhibited in time 
delays, local physiological differences are likely the primary cause of variability here.  
Anatomical locations combined with the pig’s bodily position during the 
experiment can affect blood perfusion and, hence, glucose delivery to the sensor. 
Nevertheless, both glucose-sensitive implants returned to baseline values matching the 
O2 Ref after the blood glucose levels dropped below about 80 mg/dL. This flattening of 
the low-glucose response is also consistent with the in vitro data, where there is a 
decrease in sensitivity as glucose falls to lower levels, especially when considering that 
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the diffusion coefficient of glucose is likely substantially lower in subcutaneous tissue 
compared to the in vitro flow cell setup. 
Pertaining to the scatter plot (Figure 3-9, right), measured real-time, uncorrected 
single-point lifetime values are plotted against the average blood glucose values obtained 
from the same blood droplet using three glucometers (horizontal error bars indicate one 
standard deviation in blood glucose). Channel 2 shows consistent clustering of lifetime 
values for similar glucose values, whereas channel 1 exhibits significant hysteresis in the 
measurements indicating a less reversible sensor response. This difference results from a 
different delay period observed for rising versus falling glucose levels (the higher levels 
represent measurements made on the falling edge). These differences are attributed to 
the local tissue environment, which will have unique characteristics related to the 
specific short-term host response to each implant. In practice, this may result in the need 
to calibrate the device more frequently throughout the day, as trends predicted as the 
glucose is rising may not accurately predict the rate at which glucose decreases. Errors in 
predicted blood glucose changes could result in under correction or over correction of 
rising and falling blood glucose levels, causing the patient to administer improper insulin 
dosages.  
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Because the study mentioned above was conducted on the sacrifice day of the 
pig, longer-term studies with the 75:25 HEMA:AAm formulation were conducted in a 
subsequent pig. In Figure 3-11, glucose challenge data are shown after seven days of 
implantation. Although the baseline lifetime (~1500 seconds) starts around 60 
microseconds (similar to the day 0 timepoint presented in Figure 3-8), there is a more 
pronounced time lag throughout the duration of the glucose challenge. Furthermore, 
while the “fresh” implants (day 0) exhibited a uniform bell-shaped curve that closely 
followed the measured blood glucose levels in real-time and promptly declined after the 
administration of glucose, the response at day 7 assumed more of a plateau shape 
starting around 4000 seconds into the glucose challenge while the measured blood 
glucose levels continued to rise. While the blood glucose began declining shortly after  
 
Figure 3-11: In vivo responses of a pHEMA-co-AAm 
hydrogel subcutaneous sensor seven days after implantation. 
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5000 seconds, the measured sensor lifetime did not reflect this change until ~1500 
seconds later. These differences can be attributed to the foreign body response around 
the implant which is known to involve highly metabolic cells such as macrophages, and 
the formation of granular tissue on the order of days once a material is implanted in the 
body. Not only could the presence of cells and granulation tissue affect the diffusion of 
glucose and oxygen to the sensor by physical means, the immune cells could also 
consume both substrates in an effort to carry out their natural immune response cascades 
and ultimately resume homeostasis [33, 38, 125, 126]. 
It is also worth mentioning that no glucose modulation was observed past seven 
days of implantation. Starting baseline luminescence lifetimes of glucose sensors were 
over 200 µs (Figure 3-12), indicating extremely low oxygen concentrations near the 
sensor. A starting luminescence lifetime of ~200 µs indicates extremely low oxygen 
concentrations, as this signal level is close to the natural lifetime of the dye (lifetime in  
 
Figure 3-12: Comparison of glucose responses of the same sensors in 
the same pig one week and three weeks after implantation 
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the absence of oxygen). Representative results showing decrease in response to glucose 
from one to three weeks of implantation can be seen in Figure 3-12 below; week one and 
week three sensors are identical in formulation and from the same pig. Because of this 
drastic loss in sensor response at three weeks, these experiments highlight the need to 
investigate and refine substrate transport balance throughout the matrix.  
3.4. Conclusions 
This chapter shows that enzymatic sensors based on monitoring phosphorescence 
lifetime in copolymer hydrogels can be designed to respond to glucose concentrations in 
vitro up to 200 mg/dL. These materials also demonstrated the ability to monitor blood 
glucose levels over hyperglycemic, euglycemic, and slightly hyperglycemic blood 
glucose concentrations in vivo using a porcine model. This study demonstrates the first 
successful tracking of real-time in vivo glucose response from a fully implantable 
enzymatic glucose sensor measuring luminescence lifetime instead of intensity [77]. 
Therefore, this work represents an important advance toward non-invasive monitoring of 
injected sensor devices for chronic disease and personal health management. It is 
important to note that these data involve only the response of freshly implanted sensors. 
Long-term foreign body response effects (i.e., on the order of months) are not considered 
here. However, the fully-implantable nature of these systems reduces the chances of 
infection and physical stresses that can cause chronic tissue irritation. Furthermore, 
advances in specialized materials (e.g., microporous structures) provide promise that 
such hydrogels could meet the requirements for safe, effective, and minimally invasive 
long-term monitoring. Future work will involve conducting long-term stability tests in 
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vivo in porcine models and in vitro under physiological storage conditions for this 
particular copolymer/enzyme/porphyrin sensor formulation as well as other promising 
candidate materials. Additionally, the hydrogel chemical properties will be tailored to 
increase the analytical range measured in vitro with the ultimate goal of extending the 
device’s in vivo functional lifetime. 
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4. INVESTIGATING OXYGEN TRANSPORT AND ENZYME STABILITY* 
 
4.1. Introduction 
As discussed in Chapters 2 and 3, development of a biocompatible glucose 
sensor requires the device to function in its application long-term, despite any FBR 
effects that may alter the ability of substrates to diffuse throughout the sensor and/or the 
substrate oxidation reaction to catalyze. Because of drastically fluctuating physiological 
conditions around the sensor implants during the wound healing phase, extending the 
operational lifetime of a fully implantable sensing platform long-term in vivo has yet to 
be realized. To optimize the in vivo operational lifetime of these devices, an a priori 
understanding of the relationship between matrix chemistry and device performance 
metrics must be established. Detailed study of the impact of hydrogel matrix properties 
on substrate diffusion and overall sensor response should impart knowledge necessary 
for improved rational sensor design and optimized function. 
 Loss of enzymatic activity affects overall device performance. With 
multicomponent systems such as these flux-based sensors, it is difficult to troubleshoot 
changes in overall device performance among formulations without foreknowledge of 
enzyme-matrix interactions and how a particular hydrogel formulation may stunt or 
accelerate enzyme activity loss. By the same token, designing a device without such a 
                                                 
* Parts of this section are reprinted with permission from R. M. Unruh, J. L. Weaver, and M. J. McShane, 
"Hydrogel matrix effects on oxygen diffusion: Controlling properties for biosensor applications," in 2015 
IEEE SENSORS, Busan, South Korea, 2015, pp. 1-4: IEEE Xplore, 2015. © 2015 by IEEE. 
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knowledge base can prove to be a time-consuming and expensive affair. With the vast 
material combinations and immobilization techniques, a method to rapidly screen 
enzyme/material combinations is necessary to build an adequate library of a priori 
knowledge for rational device design. 
Some efforts have been made to quantify apparent activity of GOx immobilized 
in hydrogels. The Peppas group has monitored apparent activity of immobilized GOx by 
measuring the pH drop over time in a GOx microparticle suspension [115]. However, the 
efficacy of this method could be hindered in buffered solutions designed to resist pH 
change. Additionally, the reaction rate of GOx itself is pH-dependent, changing the 
apparent activity as an effect of changing pH levels. The Ratner group has developed a 
method for measuring apparent GOx activity assay whereby acid production levels are 
monitored and the pH is maintained by titration of sodium hydroxide; GOx apparent 
activity can be measured by measuring total volume of sodium hydroxide added [138]. 
However, this method requires relatively large volumes of assay liquid, and its 
throughput is low since only a single gel sample can be tested at a time with standard 
titration devices. Liu et al. have employed an endpoint assay to assess the bioactivity of 
GOx-loaded alginate microbeads based on the Trinder method, which uses 4-
aminophenazone as a colorimetric indicator of peroxide production [139].  Brahim et al. 
used an endpoint method for GOx-loaded pHEMA gels to spectrophotometrically detect 
peroxide levels with dimethylaminobenzoic acid [109]. The nature of these endpoint 
assays is that they only provide discrete measurements of peroxide level within a 
sample, preventing observance of real-time peroxide production. Sensors with 
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functionalized with GOx and a porphyrin dye operate under diffusion-reaction balance, 
proving difficult to determine steady-state behavior without real-time monitoring [22, 
24, 28, 65, 140]. When determining apparent activity of enzyme-loaded gels, a method 
to observe the peroxide production profile is helpful to ensure that the assay is run long 
enough to achieve the reaction-diffusion equilibrium (i.e., linear peroxide production 
versus time). The goal for the present study were to (1) increase throughput of the 
number of hydrogels tested at a given time, (2) avoid dependency on pH changes to 
detect GOx apparent activity, and (3) maintain the ability to monitor the GOx reaction in 
real time while minimizing reagent volume. 
In this study, a term coined the “apparent enzymatic activity,” a term assimilating 
diffusivity and reactivity of immobilized enzyme/substrate platforms into one metric, is 
applied and quantified. pHEMA and poly(acrylamide) hydrogels were chosen as the 
immobilization substrate based on their optical clarity abundant use in chemical and 
biomedical applications [28, 65, 95, 108, 109, 111, 138, 140-147]. 
A series of pHEMA copolymer formulations were fabricated with equivalent 
amounts of total protein, but with varying amounts of GOx enzyme, and tested for 
apparent activity using an absorbance-based assay and a plate reader. The scope of this 
section is to outline the methodology used to quantify apparent GOx activity and set the 
stage for developing the aforementioned library of a priori knowledge of GOx/material 
interactions as a segue for optimized material selection for enzyme-containing devices. 
Detailed study of the impact of hydrogel matrix properties on substrate diffusion and 
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overall sensor response will impart knowledge necessary for improved rational sensor 
design and optimized function. 
Toward this aim, a series of experiments are designed to investigate how matrix 
chemistry affects glucose and oxygen transport, GOx stability, and the overall sensor 
performance. These experiments are organized into several overarching thrusts: (1) 
identify an array of promising alternative hydrogel materials to pHEMA-co-AAm and 
screen these materials in a high-throughput manner to hone in on promising material 
candidates for enzyme stability over a one-month timeframe, (2) filter out the most 
promising material candidates from thrust 1 to quantify substrate diffusion, and (3) test 
the overall sensor response profile on the formulations from thrust 2 and relate the 
response to the various sensor metrics and figures of merit. 
4.2. Experimental Methods 
4.2.1. Materials 
GOx was purchased from BBI Enzymes (Cardiff, UK). TEGDMA and HEMA 
were purchased from Polysciences (Warrington, PA). Sodium acetate trihydrate, 
horseradish peroxidase (HRP), o-dianisidine, 2,2-dimethoxy-2-phenyl-acetophenone 
(DMAP), ethylene glycol, and 1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide 
hydrochloride (EDC) were purchased from Sigma (St. Louis, MO). Sodium chloride, 
potassium chloride, potassium phosphate (dibasic), sulfo-N-hydroxysuccinimide (sulfo-
NHS), and DMSO were purchased from VWR® (Radnor, PA). Sodium phosphate 
(monobasic) was purchased from ACROS Organics (ThermoFisher Scientific, Waltham, 
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MA). Acrylamide was purchased from AMRESCO (Solon, OH), and glucose was 
purchased from Macron Fine Chemicals (Center Valley, PA). 
4.2.2. Hydrogel Fabrication 
Hydrogels were fabricated according to previously described methods (Section 
3.2.2) with a few slight changes [65]. In some formulations, the type of comonomer(s) 
was changed. Comonomers investigated here include AAm, N, N-dimethylacrylamide 
(DMA), N-vinylpyrrolidone (NVP), and 3-[Tris(trimethylsiloxy)silyl] propyl 
methacrylate (TRIS), with each formulation  
 
 
  
Figure 4-1: Structures of selected hydrogel matrix components (monomers and crosslinkers)  
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Table 4-1: Table of monomer combinations. Both 75:25 and 50:50 HEMA:comonomer 
ratios were tested for each formulation (with the exception of the pHEMA 
homopolymer). 
Hydrogel Formulations with TEGDMA Hydrogel Formulations with EGDMA 
pHEMA pHEMA 
pHEMA-co-AAm pHEMA-co-AAm 
pHEMA-co-DMA pHEMA-co-DMA 
pHEMA-co-NVP pHEMA-co-NVP 
pHEMA-co-TRIS pHEMA-co-TRIS 
 
 
containing at least 50% HEMA (Figure 4-1, Table 4-1). These materials were chosen 
based on their established use in biomedical applications, such as contact lenses (HEMA 
and TRIS), their hydrophilicity and ability to enhance hydration of the gel matrix (AAm, 
DMA, and NVP), and their notable oxygen transport (TRIS, DMA) [148]. 
 Gels for Screening 
All gel precursors contained 250 µL of monomers (HEMA and necessary 
comonomers), 2.5 mg of DMPA, 5 µL of crosslinker (TEGDMA or EGDMA), 50 µL of 
dye solution in DMSO, 90 µL of ethylene glycol, and 107.5 µL of protein solution (GOx 
or GOx + bovine serum albumin (BSA), see table below). Precursors were injected into 
glass slide molds with 0.01-in.-thick Teflon spacers. Gels were photopolymerized with 
UV light (365 nm, 140 watts, three minutes per side). The resulting crosslinked gels 
were removed from the mold, rinsed with DI water, and placed in 40 mL of PBS.  To 
further immobilize GOx in the gels, 5.6 mg of EDC and 16 mg of sulfo-NHS were 
dissolved in 250 µL of PBS and added to the tube containing the PBS and polymerized 
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gel slab. Gels in PBS with EDC/sulfo-NHS were allowed to equilibrate overnight on a 
nutating mixer (VWR) at room temperature. 
 
 
 
After overnight equilibration in PBS, hydrogel discs (5-mm diameter) were 
punched with a biopsy punch and placed in tea balls for incubation under physiological 
conditions (explained in Section 4.2.3). This is one key change in the experimental setup 
from the thermostability screening experiments conducted in Chapter 3, Sections 3.2.2.1 
and 3.3.1. Additionally, the phosphor used in these screening experiments was 
tetracarboxylated instead of tetramethacrylated (PdBP-acid, Figure 4-2). Only for the 
purposes of these screening experiments was a tetracarboxylated dye used. The reason 
Figure 4-2: Structure of the tetracarboxylate benzoporphyrin (PdBP-acid) 
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for changing the dye stems from the fact that the tetramethacrylated form of the dye acts 
as an additional crosslinker to the matrix. The goal of this study was to isolate the matrix 
properties themselves and evaluate their effect on enzyme stability without any change 
in water content or substrate transport from the sensing assay itself. In other words, the 
matrix chemistry itself should be the only factor to influence enzyme stability. Chapter 2 
established that PdBP solubility can vary with precursor formulation chemistry, 
especially the tetramethacrylated version of the dye. If the dye, which could precipitate 
in some precursor solutions, forms covalent bonds with the polymer matrix but is not 
completely dissolved, then the amount of total polymerizable crosslinker could vary 
from formulation-to-formulation, introducing an unnecessary variable into the 
experiment. 
While it is beneficial to have a benzoporphyrin physically present in the hydrogel 
matrix because the enzyme itself could physically interact with the dye (and to keep the 
enzyme environment as consistent as possible with the implanted sensors for the sake of 
consistency in this specific application), the goal of this study was to identify promising 
gel matrix candidates for promoting enzyme stability in general using this GOx-based  
sensing platform as a model example of a system requiring optimal enzyme stability. In 
order to translate findings from this study to other enzymes for other applications, the 
results should not depend on the use of an additional crosslinker such as PdBP. 
4.2.2.1.1. Screening Experiment Set One 
For the first set of experiments, GOx (2.3 µM) was added to the gel formulations 
equivalent to the GOx concentration used in Chapter 3 thermostability screening 
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experiments (Section 3.2.2.1). The difference between these experiments and the 
screening experiments in Chapter 3 is that here GOx was incubated in glucose (100 
mg/dL) in PBS at 37 °C, as opposed to only PBS at 37 °C (illustrated in Figure 4-3), and 
was tested for apparent activity over a longer period of time (four weeks versus two 
weeks in Chapter 3). Keeping the GOx concentration the same as in previous 
thermostability experiments allowed a direct comparison of incubation with and without 
glucose for the same GOx concentration. 
 
 
Figure 4-3: Tea wash incubation setup showing gel discs encased in a tea strainer 
with the chain strapped to the exterior of the beaker. Beaker is filled with PBS, 
covered with parafilm, and placed on a magnetic stir plate in an incubator at 37 °C. 
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4.2.2.1.2. Screening Experiment Set Two 
For the second set of screening experiments, gels were fabricated as stated in 
Section 4.2.2.1.1, but the total protein content in the protein solution added to the 
precursor was kept constant at 40.0 mg/mL, equivalent to the mass of protein in the 
sensor implant precursor solutions. Various ratios of BSA to GOx in the protein solution 
were investigated while keeping the total protein content constant at 40.0 mg/mL (Table 
4-2). The rationale behind adding BSA to the gels is that enzyme stability is 
concentration-dependent [43]. 
BSA has been used as a stabilizing excipient in solution-phase and solid-surface 
protein immobilization processes, acting as a molecular chaperone or excipient [149-
152]. Reducing the overall protein content initially allows a sufficient working range of 
the assay and a more direct comparison to initial screening studies conducted in Chapter 
2. However, enzyme stability is known to be concentration-dependent and could 
exacerbate enzyme deactivation and negatively impact long-term stability (on the order 
of weeks) [102, 153]. 
While the purpose of this study is to investigate the effect of matrix chemistry on 
enzyme stability in hydrogels by using GOx as a model enzyme, GOx stability results 
from these screening experiments can also be used as a first-pass test to identify 
promising hydrogel formulations for implantation. However, one should be mindful of 
the fact that the GOx concentrations used thus far have been significantly less than the 
GOx concentrations used in implants, albeit due to different testing conditions during 
screening tests (static fluid) versus implant strip tests (continuous fluid flow). Because 
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GOx stability is concentration-dependent, one way to alleviate the effects of accelerated 
GOx deactivation is to supplement the matrix with a filler protein (i.e., BSA) to ensure 
that the total protein content is equivalent to that of the implant gels (40.0 mg/mL in the 
precursor). Additionally, this approach allows for investigating the proportion of GOx 
relative to the total protein content, a factor that could also affect the overall apparent 
activity by (1) affecting the overall amount of substrate catalyzed and (2) altering the 
rate of peroxide generation, a compound known to deactivate GOx. Because of these 
complex dynamics of enzyme catalysis and stability, the following BSA:GOx ratios 
were investigated for each candidate gel formulation, outlined in Table 1. Investigating 
various BSA:GOx ratios could reveal trends of the GOx concentration on GOx stability 
over time when the total protein content is held constant. By keeping the total protein 
constant, trends in GOx stability could be extrapolated to predict the stability of GOx at 
232.5 µM or 40.0 mg/mL, the concentration traditionally used in the implants. 
 
Table 4-2: Concentrations of BSA and GOx for each respective GOx dilution. Dilution 
factors are calculated relative to the amount of GOx used in a typical injectable sensor 
formulation. 
 
 
 
GOx Dilution Factor [GOx] (mg/mL) [BSA] (mg/mL) 
10× 4.0 36.0 
20× 2.0 38.0 
50× 0.8 39.2 
100× 0.4 39.6 
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 Gels for Testing Sensor Figures of Merit (i.e., Substrate Transport and Optical 
Response to Glucose) 
Downselected hydrogels (determined by primary screening results) were selected 
for further investigation. Promising formulations were identified by comparing the 
apparent activity retained for each gel over the four-week period. Gels exhibiting at least 
75% of the change in absorbance per second when compared to the 75:25 HEMA:AAm 
formulation were selected for further characterization (i.e., substrate transport and 
optical response to glucose).  In addition to screening results, other factors such as the 
potential for adequate substrate transport balance (i.e., increasing oxygen permeability 
and reducing glucose permeability relative to 75:25 HEMA:AAm) were considered 
when designing formulations for implantation.  
4.2.3. Hydrogel Incubation 
Once the gel slabs were fabricated, they were punched as described in Section 
4.2.2 and placed in tea strainers. The tea strainers were used for the purpose of holding 
the gel discs and allowing the incubation solution to pass through freely during the four-
week incubation period. Twenty-four discs of each formulation were placed in 
individual tea strainers and clamped closed, as well as secured with wire laterally on 
both sides of the clamp. The eight tea strainers were placed in a 2-L beaker (chains taped 
to the outside), filled with 2 L of PBS solution with 100 mg/dL glucose added, covered 
with parafilm, and placed on a stir plate in an incubator overnight. Each day, the solution 
was exchanged for fresh PBS + glucose solution. 
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Each week, to prepare the discs for apparent activity testing, six discs from each 
formulation were placed in a 15-mL centrifuge tube filled with 50-mM NaOAc buffer 
(pH 5.1) and were allowed to equilibrate overnight at 4 °C. To test for apparent activity, 
NaOAc-equilibrated gels were placed in a flat-bottom, 96-well plate as described in 
Section 4.2.4.2. 
4.2.4. Testing for Gel Figures of Merit 
 Swelling Ratios 
Hydrogels were prepared similar to methods described in Section 3.2.2.2, except 
the PdBP-acid dye was used in place of the PdBP dye and monomers were altered 
according to the desired formulation to polymerize. After photocuring and equilibration, 
five discs from each formulation were punched with a disposable biopsy punch (5 mm 
diameter, VWR). Each disc was blotted on a Kimwipe to remove excess water and then 
was weighed on an analytical balance (Mettler Toledo) to obtain the hydrated mass. The 
gel discs were dried under the house vacuum overnight (>24 hours) and weighed again 
to obtain the dried weight (Wd). The swelling ratio (equilibrium water content, EWC) 
was calculated from the percent difference in the two weights according to the following 
equation: 
𝐸𝑊𝐶 =  
𝑊𝑠 −  𝑊𝑑
𝑊𝑑
∗ 100 
 Glucose Oxidase Stability—Absorbance-Based Apparent Activity Assays 
In order to maximize the number of formulations tested, the apparent activity of 
the enzyme was tested in the highest-throughput manner possible. In order to accomplish 
this, 5-mm diameter discs loaded with GOx, BSA, and PdBP-acid were punched from 
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each hydrogel slab and placed in a 96-well plate for the purposes of quantifying the 
apparent activity using an o-dianisidine colorimetric absorbance assay. The discs were 
tested for initial apparent activity, as well as stability over a one-month period by 
incubating under physiological conditions (PBS, pH 7.4, 37 °C, 100 mg/dL glucose). 
Discs were cut from a hydrated gel slab (Figure 4-4, step 1) and prepared for 
testing  by soaking in sodium acetate buffer (NaOAc, 50 mM, pH 5.1, 4 °C) overnight in 
a 15-mL centrifuge tube on a nutating mixer (Figure 4-4, steps 2 and 3). The following 
day, the tubes containing gels soaked in sodium acetate were removed from refrigeration 
and placed in an incubator to warm them near the assay temperature (35 °C) and 
minimize the temperature gradient between the storage condition (4 °C) and the assay 
testing condition (35 °C). 
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To conduct the assay, a reaction cocktail of glucose, o-dianisidine, and HRP in 
sodium acetate was prepared according to established protocols [129]. Concentrations of 
each ingredient were made according to a standardized assay method for free GOx 
enzyme [129]. Gels were tested for GOx apparent activity after initial overnight soaking 
in PBS (week 0) and weekly thereafter for three additional weeks after exposure to 
physiological conditions (solution containing PBS at pH 7.4 and 100 mg/dL of glucose 
Figure 4-4: (Top) Gel disc preparation and assay setup scheme; (Bottom) 
Illustration of the colorimetric change which occurs due to the coupled 
redox reactions in the assay. 
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at 37 °C; solution changed daily). All gels were prepared for screening tests by placing 
the gel discs into 15-mL centrifuge tubes containing sodium acetate buffer at pH 5.1 for 
24 hours before running the assay. The next day, the gels were placed in wells of a 96-
well plate, and 200 µL of reaction cocktail was dispensed into each well. For each 
timepoint, a fresh GOx standard solution (9.73-nM enzyme in NaOAc buffer at pH 5.1) 
was prepared. Briefly, a 2-mg/mL solution of crude protein reagent was made in NaOAc 
buffer, pH 5.1. This solution was diluted 1000× in the NaOAc buffer to achieve the final 
GOx concentration. The GOx reagent was determined to be 78% enzyme via UV-Vis. A 
plate reader (Tecan, Infinite 200 PRO) was used to measure solution absorbance at 495 
nm in one-minute kinetic interval cycles for 30 minutes (30 kinetic cycles). 
The absorbance versus time for each sample was plotted, and the linear portion 
of the curve was used to identify where GOx was reacting at its maximum velocity, 
Vmax. The slopes of the linear portion of each curve for each sample were used to 
determine the comparative apparent activity among all samples. This procedure was 
performed after fabrication and weekly upon storage in 100 mg/dL of glucose in PBS at 
37 °C for one month. 
 Substrate Transport 
4.2.4.3.1. Oxygen Diffusion—Stern-Volmer Kinetics 
     Stern-Volmer oxygen diffusion experiments were carried out similar to the methods  
described in Section 3.2.3.3 and Figure 3-5. Gel strips (0.75 × 0.75 × 5 mm) were tested 
according to previous methods [28, 65]. Phosphorescence lifetimes were recorded using 
the previously described custom optical interrogation system with a pulsed LED and 
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silicon PMT (SensL). Sensors were exposed to various oxygen levels (0, 2, 5, 10, and 21 
%O2) using a custom benchtop system controlled by two mass flow controllers and were 
confirmed with a picoammeter (Figure 3-5). 
4.2.4.3.2. Sucrose Diffusion 
Gels for sucrose diffusion were fabricated as described in Section 4.2.2.1 for 
screening—0.01-in.- (~250-µm-) thick Teflon spacer, glass slide mold—in order to 
minimize the path length for the saccharide to permeate from the feed chamber (thus  
 
expediting results), through the gel, to the permeate chamber. Horizontal side-by-side 
diffusion cell systems were used as detailed in prior work and illustrated in Figure 4-5 
[28, 65]. Square gel cutouts (1 × 1 in.) were immobilized between two reservoir chambers 
Figure 4-5: Illustration of Side-by-Side diffusion cell setup. 
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(one feed chamber with analyte in PBS and one permeate chamber with only PBS). Feed 
reservoirs contained a 22.2-mM sucrose solution (equivalent to the molar concentration 
of glucose in blood at the upper end of the physiological hyperglycemic range); choosing 
a hyperglycemic initial feed chamber concentration created a greater concentration 
gradient between the feed and permeate chambers, decreasing the time to detect a 
measurable sucrose concentration on the permeate side and thus decreasing the overall 
experiment time for each formulation. 
 Sucrose was used as a surrogate analyte for glucose due to low GOx selectivity 
for sucrose. Permeate reservoirs contained pure PBS solution. To determine the rate of 
sucrose diffusion, samples were taken from both chambers three times daily and analyzed 
using a YSI 2700 Select Biochemistry Analyzer (Yellow Springs, Ohio). A linear fit was 
applied to the [sucrose] versus time data to calculate the concentration change rate. To 
calculate a relative diffusion coefficient, Fick’s second law of diffusion was used, 
assuming homogeneous mixing and the following boundary condition: [sucrose] = 0 mM 
at t(0) in the permeate chamber [10]. Applying these conditions yields the following 
equation: 
𝐷 =  
𝑑𝐶
𝑑𝑡
(
𝑙𝑉
ΦA𝐶0
) 
where 𝐷 is the diffusion coefficient of sucrose in cm2/s, 
𝑑𝐶
𝑑𝑡
 is the change in permeate 
reservoir analyte concentration over time, 𝑙 is the gel thickness, 𝑉 is the chamber volume, 
𝐴 is the surface area of the orifice between the two chambers, 𝐶0 is the initial 
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concentration of sucrose in the feed chamber at t=0, and 𝜙 is the partition coefficient 
(assumed to be 1, as the apparent diffusivity was of prime interest for these purpose of 
this study). All formulations were tested in triplicate at 25 °C. 
 Optical Response to Glucose 
  In this study, sensors were tested at ambient oxygen (21%) using a flow-through 
system as described in Figure 3-4, Section 3.2.3.2. Glucose levels were modulated from 0 
mg/dL (baseline lifetime) to 50, 100, 200, and 400 mg/dL before returning back to 
baseline levels (0 mg/dL). Glucose concentrations were changed in a step-wise manner 
and kept constant until sensors reached a steady-state response.  
 Homogeneity Visualization—Confocal Laser Scanning Microscopy 
Staining of the gels with Nile Red was adapted from Bailey, et al. 2012 [154, 
155]. First, a 20-mg/mL solution of Nile Red (Sigma) in methanol was dissolved in a 
dram vial by vortexing for one minute. A 75-µL aliquot of this dye solution was added 
to 8 mL of DI water in a 20-mL scintillation vial and was vortexed for one minute. Next, 
the 8-mL solution was diluted by adding it to 120 mL of PBS in a beaker under constant 
stirring. Gel discs (5-mm diameter) were punched from the gels with a biopsy punch. 
Each disc was placed in a separate centrifuge tube filled with 50 mL of the diluted Nile 
Red solution in PBS and was placed on a nutating mixer at room temperature for 24 
hours. After 24 hours, the Nile Red solution in PBS was discarded, and the stained gel 
discs were placed in fresh centrifuge tubes with 50 mL of fresh PBS, allowing nutation 
at room temperature for 24 more hours. The washing process was repeated three times, 
and the discs were stored in PBS until imaging. 
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Confocal Laser Scanning Microscopy (CLSM) images were taken on an 
Olympus FV1000 confocal microscope. Excitation of the Nile Red stained gels was 
accomplished with a helium-neon laser (543 nm); emission was collected from 650 to 
700 nm. Images were obtained 100 µm into the sample. 
4.3. Results and Discussion 
4.3.1. Swelling, Apparent Activity, and Stability—Screening 
 Swelling and Initial Apparent Activity 
Gel discs for swelling were weighed and thickness was measured with calipers. 
Percent changes were calculated as described in Section 4.2.4.1. These data were 
collected and plotted for comparison to initial apparent activity values, which were 
gathered as described below. For screening initial apparent activity, gel discs, as well as 
a GOx standard (2 µg/mL in 50-mM NaOAc buffer, pH 5.1), were loaded into a 96-well 
flat-bottom polystyrene well plate, as depicted in Figure 4-6. This configuration was 
maintained for the duration of the study. Assays were run according to methods outlined 
in Section 4.2.3.2, and results are presented in Figures 4-7 and 4-8. 
With the exception of the 50:50 HEMA:AAm and 50:50 HEMA:DMA 
(TEGDMA crosslinker only), initial apparent activity of the GOx increased with 
increasing water content, likely due to increased permeability to glucose with increased 
water content. Considering the two exceptions to this behavior stated previously, the 
observed behavior can be attributed to (1) lower concentration of enzyme per unit 
volume of gel after equilibrating in water and (2) more GOx release from the surface of 
the gel after fabrication versus other formulations. The 50:50 HEMA:AAm formulation 
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had the highest variability in initial apparent activity of all formulations tested (both 
TEGDMA and EGDMA crosslinked formulations).  Overall, the correlation between 
apparent activity and thickness (Δt) is not as strong, which can be attributed to manual 
measurement error with the calipers. 
  
Figure 4-6: Sample diagram of gel layout in well plate for screening assays. 
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Despite the outliers stated in the previous paragraph, apparent activity increases 
with increasing swelling ratio. This is expected because increased swelling results in a 
decreased barrier to glucose, thus increasing glucose diffusion. Because this is a flux-
based, diffusion-reaction system, the rate of glucose transport into the system (dC/dt) 
will increase as the diffusion coefficient value (D) increases according to the following 
equation. 
 
𝑑𝐶
𝑑𝑡
= 𝐷
𝑑2𝐶
𝑑𝑥2
+ 𝑟(𝐶) 
 
Some formulations did not follow the trend between initial apparent activity and 
swelling ratio; there are some possible explanations for these outliers. First, the discs 
tested may have had less GOx encapsulated from the start given prior solubility issues 
with GOx in these pHEMA-based precursors. GOx precipitation could lead to 
inhomogeneous dispersion of the enzyme throughout the gel matrix, leading to some 
gels having less GOx than others. However, this is an unlikely cause due to the fact that 
these outlying formulations have only 50% HEMA, and previous results in Chapter 3 
indicated that gel formulations with higher HEMA contents induce more GOx 
precipitation; GOx is more likely to be distributed more homogeneously in the outlying 
formulations containing 50% HEMA content. Another, more probable cause is that GOx 
could leach out of the matrix after fabrication during PBS equilibration.  This is a more 
likely cause due to the fact that the outlying gel formulations seen here have two of the 
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highest swelling ratios (based on EWC), which could facilitate enzyme diffusion out of 
Figure 4-7: Initial apparent activity values (absorbance/second slopes) plotted alongside 
swelling ratio values (EWC) and gel thickness (percent change from wet to dry) to show 
the effects of water content on GOx apparent activity. Error bars represent 95% 
confidence intervals (n = 5). 
[Grab your reader’s attention with a great quote from the document or use this space 
to emphasize a key point. To place this text box anywhere on the page, just drag it.] 
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highest swelling ratios (based on EWC), which could facilitate enzyme diffusion out of 
the gel matrix. Based on this conjecture, it is recommended that enzyme leaching 
experiments be conducted after gel fabrication before starting apparent activity screening 
and stability studies. 
 Screening Experiment #1—Without Bovine Serum Albumin Excipient 
According to Figure 4-7, while all gels were active on week 0, with a direct 
correlation between initial apparent activity and EWC, nearly all gels lost >90% of their 
apparent activity within the first week of incubation (Figure 4-8). Two formulations 
showed an exception to this observation: pHEMA and 75:25 HEMA:NVP, both with the 
EGDMA crosslinker. Although there was no statistically significant difference between 
week 0 and week 1 values with these formulations, with the pHEMA formulation, the 
error bars overlap with the x-axis. Therefore, one could say that the pHEMA 
homopolymer gels were “statistically dead” after one week of incubation. Moreover, 
there is a negligible difference in the type of crosslinker to preserve enzymatic activity, 
so TEGDMA was used for all subsequent experiments. 
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there is a negligible difference in the type of crosslinker to preserve enzymatic 
activity, so TEGDMA was used for all subsequent experiments. 
Figure 4-8: Stability over four weeks of gels with 100× dilute 
GOx (concentration used in Chapter 3). No BSA added. 
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 Screening Experiment #2—With Bovine Serum Albumin Excipient 
Adding BSA to the gels allowed for a more thorough investigation into the 
conditions of GOx deactivation during these specified physiologically relevant 
incubation conditions. In Figure 4-9, initial apparent activity results are presented (raw 
data). The data show similar apparent activity levels as reported in Figure 4-7 with the 
exception of the pHEMA gel with 100× dilute GOx. Less immobilized GOx could 
explain the abnormally low apparent activity seen for this formulation; however, this 
formulation had very low apparent activity during the entire month-long study. Although 
apparent activity levels on weeks three and four showed 2.5 and 1.6 times more apparent 
activity, respectively, than week 0 values for pHEMA with 100× dilute GOx, these 
levels are still lower than the HEMA gels with higher amounts of GOx. This suggests 
that these gels had little to no GOx activity throughout the entire experiment.   
 
Figure 4-9: Initial apparent activity values of GOx, screening 
experiment 2, BSA added as an excipient. 
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A 
B 
Figure 4-10(A-B): Four-week stability of pHEMA-co-DMA and pHEMA-co-NVP 
copolymer gels with BSA added. 
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C 
D 
Figure 4-10 (continued, C-D): Four-week stability of pHEMA-co-DMA and 
pHEMA-co-NVP copolymer gels with BSA added. 
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No apparent improvement in GOx stability was observed in any of the pHEMA-
co-AAm formulations upon adding BSA, but more evidence of GOx stability was 
observed in both the DMA and NVP copolymer formulations with BSA (Figure 4-10). 
Considering the pHEMA homopolymer gels specifically (Figure 4-10A), one likely 
reason for the lack of stability is BSA and GOx precipitation. It was established in 
Section 3.3.1 that most of the GOx added to a pHEMA hydrogel precursor precipitates 
out of solution. This could result in GOx “clumping” in the matrix. Not only is clumping 
undesirable from the perspective of homogeneity and sensor response repeatability, it 
also potentially causes two other unwanted results: (1) GOx is not able to be protected 
by the matrix because of the enzyme aggregates throughout the gel and/or (2) GOx is not 
adequately immobilized in the matrix, but is rather held in the sensor by interacting with 
the other enzyme molecules in the precipitate, which, upon hydration, could allow GOx 
to leach out of the matrix and cause the entire gel to lose its apparent activity. 
In the case of the AAm copolymers, similar drastic loss in GOx apparent activity 
was observed (Figure 4-10B). This is contrary to what was expected because AAm 
polymers and copolymers have been used widely in the literature to immobilize proteins 
and enzymes, including GOx [141, 144]. Based on this fact and the observations from 
Section 3.3.1, it was expected that adding AAm would improve GOx stability. However, 
most previous studies reporting successful GOx immobilization in AAm gels do not 
report encapsulating another macromolecular species, such as a hydrophobic dye like 
PdBP. As shown in Section 3.3.1, PdBP precipitates in the aqueous AAm solution. It is 
hypothesized that the dye aggregates could also affect the stability of GOx. For example, 
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PdBP contains both bulky aromatic rings that could interact with hydrophobic side 
chains on amino acid residues like tyrosine and tryptophan, as well as carboxylic acids 
that could stabilize charged amino acid residues like arginine. PdBP could, when 
dispersed throughout the matrix, stabilize GOx through secondary bonding interactions 
just as other hydrophilic/hydrophobic molecular excipients have been shown to do [153]. 
When precipitated, these added benefits could be nullified. Finally, upon precipitation of 
the dye in the precursor solution, some monomer (HEMA and/or AAm) or crosslinker 
(TEGMDA) could coprecipitate in the dye aggregates, preventing them from being 
accessible to polymerize. This could lead to a less homogeneous matrix overall, which 
could also impact GOx stability. 
Contrary to pHEMA and pHEMA-co-AAm, both DMA and NVP copolymer gels 
showed an improvement in preserving the apparent activity (Figure 4-10C-D). Although 
DMA has not been used as extensively as other poly(amides) in the protein 
immobilization literature (i.e., AAm) [43, 103, 106, 114, 141, 144, 146, 156], DMA is 
structurally similar to AAm with the only two methyl groups on the pendant nitrogen 
differentiating the two molecules. This allows greater solubility of both the dye (due to 
the methyl groups) and the protein (exceptionally high hydrophilicity and EWC, Figure 
4-7). 
Like DMA, NVP is also hydrophilic and has a hydrocarbon component (an 
aliphatic hydrocarbon ring pendant group) that could help promote dye solubility and 
homogeneous distribution throughout the hydrogel matrix, as poly(vinylpyrrolidone) 
films are commonly used to immobilize benzoporphyrins in the literature [91, 157]. 
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Additionally, the presence of a carbonyl in the side group of NVP (Figure 4-11) imparts 
the added benefit of being able to hydrogen-bond with other molecules in the matrix, 
such as GOx; DMA is unable to hydrogen-bond because of the two methyl groups on the 
pendant nitrogen. Binding to amino acid residues like glutamine or histidine on GOx 
could impart an additional mechanism for preserving apparent activity over time. This 
Figure 4-11: Drawing of poly(N-vinyl pyrrolidone) (green) forming hydrogen 
bonds with a hypothetical amino acid chain (blue). Hydrogen bonds are shown 
as dashed red lines. 
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property is exploited in the pharmaceutical industry, as poly(vinylpyrrolidone) is one of 
the most common excipients for drug formulations [158-160]. While AAm is able to 
form hydrogen bonds [161], it can also form hydrogen bonds with itself (intra- and 
interchain bonding) that could compete with hydrogen bonding spots on a protein 
molecule. Based on these findings and using apparent activity tests as a first-pass 
criterion to refine the hydrogel formulation design for this biosensing application, NVP 
and DMA were chosen to investigate further as promising comonomers for developing 
refined sensor design. 
4.3.2. Refined Sensor Fabrication and Characterization 
As mentioned in Section 4.1, criteria for an optimized sensor design include 
maximizing oxygen transport while limiting glucose transport in order to impart a 
dynamic range that covers the hypoglycemic through hyperglycemic ranges. The goal of 
this section of work was to design and characterize sensor formulations to meet the 
following design criteria: (1) promote GOx stability, (2) increase oxygen transport, and 
(3) limit glucose transport. While HEMA:DMA and HEMA:NVP copolymers proved 
the best for increasing GOx stability in the previous section (Figure 4-10 C-D), both 
comonomers increase hydration relative to the pHEMA homopolymer (Figure 4-7). 
Increasing hydration relative to pHEMA will likely increase glucose transport relative to 
pHEMA. Therefore, higher amounts of comonomer relative to HEMA will likely 
decrease the dynamic range of the sensor due to more rapid influx of the analyte, 
glucose. This is especially important when testing at physiological oxygen conditions in 
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vivo, where the oxygen levels are much lower and substrate transport balance is even 
more critical than at atmospheric oxygen conditions in vitro. 
The aim of this section of work was to investigate in vitro figures of merit (e.g., 
glucose response and underlying oxygen response at physiological conditions) of 
promising material candidates using screening results in Section 4.3.1 as one primary 
criterion for gel feasibility. Emerging candidates were identified based on their potential 
to extend dynamic range under physiological conditions by meeting the three 
aforementioned criteria. Based on the screening data in Section 4.3.1.3 and published 
literature on all candidate monomers investigated in this chapter (Figure 4-1) [51, 162-
166], the following formulations were chosen to investigate comparatively here: 75:25 
HEMA:AAm, 75:25 HEMA:DMA, and 60:20:20 HEMA:NVP:TRIS. These specific 
formulations were chosen based on (1) their use in previous preclinical evaluation with 
this sensing platform (75:25 HEMA:AAm), (2) their potential to increase oxygen 
permeability relative to previous standards (75:25 HEMA:DMA and 60:20:20 
HEMA:NVP:TRIS), and (3) their potential for extending dynamic range by limiting 
glucose based on properties stated in literature (60:20:20 HEMA:NVP:TRIS) [72, 167-
170]. 
 In Vitro Characterization of Candidate Formulations 
Based on the above designated criteria, results from Section 4.3.1.3, and 
hydrogel formulations reported in the literature using these materials for contact lens 
design, HEMA, NVP, and TRIS were chosen as the materials exhibiting the highest 
potential for designing a hydrogel to meet all three criteria stated above. Although TRIS 
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was not miscible with pHEMA alone, as investigated in Section 4.3.1, studies have 
discussed using 20% TRIS with HEMA and other comonomers (including NVP) for 
improved oxygen permeability and pliability of contact lenses [72, 167-170]. For this 
reason, a 60:20:20 HEMA:NVP:TRIS formulation was investigated for its ability to 
respond to glucose at physiological conditions, hypothesizing that TRIS could both 
increase oxygen permeability (high flexibility of siloxane bonds) and decrease glucose 
permeability because of its hydrophobicity. 
4.3.2.1.1. Oxygen Transport—Stern-Volmer Kinetics 
Figure 4-12 and Table 4-3 show the Stern-Volmer oxygen-quenching kinetics 
and figures of merit for all three candidate formulations. Both 75:25 HEMA:AAm and 
HEMA:DMA exhibit an extremely linear trend (R2 > 0.99) over the entire range of 
oxygen concentrations tested, whereas the 60:20:20 HEMA:NVP:TRIS formulation 
exhibits a distinct plateau in the Stern-Volmer curve from 10 to 21% oxygen, despite 
having a linear trend from 0 to 10% oxygen. The abnormal trend in Stern-Volmer 
responses is reflected in the KSV and kq-eff  values (kq-eff  = effective bimolecular 
quenching constant, accounting for immobilized dye). This plateau at higher oxygens 
has been reported in other systems where the dye exists in two states: a quenchable state 
and nonquenchable state. This arises from instability of the dye in solution (i.e., 
precipitation) or could also be a matrix-dye interaction preventing adequate quenching of 
the dye [171]. The latter —matrix-dye interactions—is the most plausible scenario here 
because the natural lifetime, τ0, of the dye is the highest for the silicone-containing gel. 
While, in theory, the τ0 values should be identical (an intrinsic property of the dye) 
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regardless of the matrix, interactions of the matrix with the dye may influence its 
apparent natural lifetime. 
Table 4-3: Figures of merit for all monolith hydrogel formulations for oxygen. 
Reprinted with permission from IEEE. © 2015 by IEEE. 
Hydrogel 
Formulation 
τ0  
(µs) 
KSV 
[(%)-1] 
kq-eff  
[10-3 (%-µs)-1] 
75:25 
 HEMA:AAm 
264.1 ± 2.7 0.33 1.25 
75:25 HEMA:DMA 238.0 ± 1.7 0.43 1.81 
60:20:20 
HEMA:NVP:TRIS 
300.6 ± 5.0 0.27 0.90 
 
Figure 4-12: Stern-Volmer curves for the four most promising formulations. 
Reprinted with permission from IEEE. © 2015 by IEEE. 
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regardless of the matrix, interactions of the matrix with the dye may influence its 
apparent natural lifetime. 
As noted above, the Stern-Volmer plot is linear from 0 to 10% oxygen. 
Therefore, the oxygen response at physiological concentrations (2 to 5% oxygen) should 
follow standard Stern-Volmer quenching kinetics. However, even though the response is 
linear at these concentrations of oxygen, the slope of the line is still lower than expected 
for this siloxane-containing material since the objective behind adding silicone was to 
substantially increase the oxygen transport. 
4.3.2.1.2. Optical Response to Glucose and Saccharide Transport 
Baseline lifetimes (τ at 0-mg/dL glucose) were lowest for HEMA:DMA and 
highest for HEMA:NVP:TRIS (Figure 4-13). Coincidentally, the baseline lifetimes 
trended inversely with the Ksv values, indicating that greater oxygen permeability 
corresponds to a lower starting lifetime due to more efficient oxygen transport. 
Additionally, HEMA:NVP:TRIS copolymer exhibited the shortest dynamic range, likely 
due to matrix inhomogeneities inhibiting oxygen transport, as seen above. Although the 
HEMA:DMA copolymer performed with the highest measured oxygen transport, the 
increased oxygen transport had minimal effect on extending dynamic range and altering 
the overall glucose response profile. This was not expected, considering the 30% 
increase in oxygen transport based on KSV. In order to increase the dynamic range 
significantly, glucose must remain the limiting reagent of the GOx reaction over the 
entire physiological blood glucose range. This could be accomplished by decreasing 
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glucose diffusion or further increasing the oxygen diffusion, both of which are efforts 
currently being pursued. 
The change in sucrose concentration over time in the permeate chambers was 
calculated by plotting the change in concentration of sucrose versus time and calculating 
the slope of the resulting linear trend. Diffusion coefficients were calculated according to 
the equation in Section 4.2.4.3.2; this was conducted for each formulation. Resulting 
sucrose diffusion coefficients, Dsucrose, are presented in Figure 4-13 and Table 4-4. 
Results indicate the fastest saccharide transport for HEMA:NVP:TRIS. On the contrary, 
the slowest saccharide diffusion was observed for the HEMA:DMA gels, an unexpected  
 
Figure 4-13: Glucose flight plans (ambient oxygen). Reprinted with permission 
from IEEE. © 2015 by IEEE. 
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Table 4-4: Figures of merit for all monolith sensor formulations for glucose. Reprinted 
with permission from IEEE. © 2015 by IEEE. 
Hydrogel 
Formulation 
Dynamic Range 
(mg/dL) 
Sensitivity 
[µs/(mg-dL)] 
Dsucrose (10
-6 cm2/s) 
75:25 
HEMA:AAm 
0.34-188 1.15 ± 0.13 0.89 ± 1.11 
75:25 HEMA:DMA 0-194 0.94 ± 0.10 0.11 ± 0.02 
60:20:20 
HEMA:NVP:TRIS 
0-82 0.44 ± 0.15 2.17 ± 4.35 
 
 
 
observation based on prior swelling ratio and initial apparent activity calculations in 
Figure 4-7, which shows 75:25 HEMA:DMA with TEGDMA crosslinker having a much 
higher swelling ratio and initial apparent activity value compared to 75:25 HEMA:AAm.  
Because the PdBP dye can act as a tetrafunctional crosslinker due to the four 
methacrylate groups, the drastic decrease in average Dsucrose is believed to be caused by  
more efficient polymerization of the dye into the hydrogel matrix in the HEMA:DMA 
sensor. These results highlight the large extent to which inhomogeneous sensor 
morphology impacts analyte transport. Large variability in saccharide transport was seen 
with sensors with pronounced morphological inhomogeneities. This likely affects the 
overall sensor response repeatability and is investigated further in the following section. 
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4.3.2.1.3. Investigating Homogeneity 
To determine whether the source of discrepancy seen with the silicone gel 
behavior is due to matrix inhomogeneities as proposed earlier, hydrogels were imaged 
by both brightfield and confocal microscopy. Results are presented in Figure 4-14. 
Interestingly, the HEMA:DMA gels were the most uniform in appearance, without any 
apparent dye precipitation or phase separation, whereas the 75:25 HEMA:AAm gel had 
granular-like precipitate structures throughout the matrix.  The 60:20:20 
HEMA:NVP:TRIS gel appeared the least uniform, likely due to phase separation. While 
it is unclear from the brightfield images which aspects of the gel matrix are phase-
separating from the rest of the sensor, a “blank” 60:20:20 HEMA:NVP:TRIS gel (matrix  
Gel  
Edge Gel  
Edge 
Gel  
Edge 
pHEMA with GOx pHEMA with PdBP 60:20:20 
HEMA:NVP:TRIS with 
Figure 4-14: Brightfield microscopy images of glucose-sensitive hydrogels with 
GOx, CAT, and PdBP. Images are at 20× magnification, and scale bars represent 100 
µm. Images illustrate granular precipitates throughout the gel in HEMA:AAm, 
distinct globular regions in HEMA:NVP:TRIS, and the most uniform dispersion 
throughout HEMA:DMA. Adapted with permission from IEEE. © 2015 by IEEE. 
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only, no sensing chemistry) was fabricated and stained with Nile Red dye according to 
methods described in Section 4.2.4.5.  A representative CLSM image is displayed in 
Figure 4-15. 
As seen in the image shown in Figure 4-15, inhomogeneities prevail throughout 
the matrix which is consistent with the findings revealed by brightfield microscopy. 
  
Figure 4-15: CLSM image of a 60:20:20 HEMA:TRIS:DMA 
gel stained with Nile Red dye revealing spherical domains of 
silicone (lighter regions) dispersed throughout the surrounding 
matrix (darker regions). 
 93 
 
However, because of the Nile Red dye sequestering to the hydrophobic silicone regions, 
the images reveal dispersed spheres distinctly brighter than the surrounding matrix, 
indicative of phase separation containing silicone in the dispersed phase as hypothesized. 
Although some spherical dispersed regions appear darker than the surrounding matrix 
(which could indicate a region devoid of dye and, hence, silicone), this is likely an 
optical effect due to the depth of the dispersed domain in the gel. A montage of slices  
(images taken at different depths into the gel sample) of the same gel specimen is shown 
in Figure 4-16. The montage reveals brighter domains closer to the surface of the gel 
Figure 4-16: Montage of confocal microscopy slices. Slices are numbered 
according to the depth of the slice in the gel sample. Increasing slice number 
corresponds to a deeper location within the gel sample. Incremental depth changes 
between slices is ~5 μm. 
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becoming increasingly darker as the depth into the sample increases while other lighter 
domains come into focus. This further supports the fact that darker regions seen in these 
images are not necessarily devoid of silicone, but rather are at a depth position in the gel 
that renders its appearance darker; an image of a slice taken closer to the surface of the 
gel may increase the brightness of these regions and harness the fluorescent properties of 
the Nile Red dye.  These principles should be taken into account in future investigations 
of gel homogeneity. 
4.3.3. Conclusions 
This chapter has described several experiments to investigate the impact of 
various aspects of sensor design on GOx stability and substrate transport to create a 
more thoughtful sensor design and eventually achieve the vision of preclinical proof of 
concept long-term (minimum of one month). In order to investigate GOx stability in a 
more systematic manner than described in Chapter 3, screening experiments were 
designed with the following improvements in order to expand the knowledge of stability 
of GOx-hydrogel constructs: 1) expand the library of GOx-loaded materials with this 
sensing platform beyond the traditional pHEMA homopolymers and pHEMA-co-AAm 
copolymers, 2) investigate in more detail the amount of GOx used in the matrix in order 
to optimize the GOx concentration, and 3) identify overarching gel chemical properties 
that enhance GOx stability. Interestingly, screening results (experiment 2, Section 
4.3.1.3) showed that both the pHEMA homopolymer and the HEMA:AAm copolymer 
gels were the least effective in preserving GOx apparent activity over one month of 
exposure to physiological conditions, despite the fact that these are the materials that 
 95 
 
have been primarily used in the past with this sensing platform because of their 
prevalence in the literature for decades in other applications involving enzyme 
immobilization [24, 98, 109]. In fact, pHEMA and HEMA:AAm copolymer gels lost 
nearly all of their apparent activity within the first week of incubation at physiological 
conditions. In contrast, gels synthesized with DMA and NVP as comonomers retained 
between 60 and 93% of the original apparent activity after one week of incubation. 
Although apparent activity in these gels steadily declined in subsequent weeks regardless 
of GOx content, the results warranted further investigation of DMA and NVP as 
comonomers. Furthermore, the ratio of GOx:BSA did not have any significant effect on 
initial apparent activity of stability the gels, indicating matrix chemistry primarily 
impacts the stability of these gels. 
Subsequent in vitro investigation of three promising formulations, based on the 
screening results, were subjected to tests quantifying substrate transport and overall 
optical response to glucose. These results of these studies revealed other aspects of 
matrix chemistry that affect sensor function, namely matrix homogeneity. By performing 
tests to quantify the underlying oxygen response as well as overall glucose response, 
these studies further revealed the importance of avoiding precipitation or phase 
separation within the sensor construct. Because of these findings, it is recommended for 
subsequent studies that approaches to sensor design be taken with the mindset of 
ensuring dispersion of all sensor components instead of taking a one-step, “brute force” 
approach to sensor design. By allocating extra effort on the “front end” (i.e. before 
preclinical testing) to systematically evaluate matrix homogeneity and ensure 
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meticulous, precise control over sensor properties independently of one another during 
the fabrication process, time to preclinical testing should be reduced. 
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5. HYBRID MATERIALS  
 
5.1. Introduction 
In the previous section, approaches were taken to investigate GOx stability in a 
variety of formulations in order to hone in on the most promising formulations and try to 
optimize hydrogel design metrics through connecting enzyme stability with other sensor 
figures of merit (i.e., substrate transport, dynamic range, and sensitivity). However, 
using DMA and TRIS as comonomers with HEMA only marginally improved GOx 
stability and had little impact on overall sensor performance. Furthermore, 
functionalizing these single-network monolith gels with the enzyme-porphyrin assay 
required a “brute force,” one-size-fits-all approach, confounding the effects of various 
factors and their impact on sensor figures of merit. Without the ability to decouple 
various physicochemical gel properties (i.e., substrate transport, hydration, mechanical 
properties, and sensing chemistry solubility) from one another, there is an inability to 
optimize, or at least fine-tune, the overall sensor response. This chapter expands on the 
prior monolith work by utilizing IPN hydrogels synthesized using a sequential 
polymerization process. Ideally, an approach to tune gel properties in an on-demand 
fashion would pave the way for optimizing glucose sensor longevity in vivo. However, 
because the overall glucose response relies on the underlying oxygen response, 
optimizing the oxygen transport in the gel matrix independent of matrix chemistry or 
hydration is a large step forward in optimizing glucose sensor design. 
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IPN hydrogels are an emerging class of materials that have gained interest 
because of the ability to use two polymer materials that may have inferior properties 
(e.g., brittleness, low hydration) as standalone, single-network gels, but, when combined, 
act in synergy with each other to yield properties superior to those of either polymer 
network alone [165, 172-174]. IPNs are defined as two networks that have no covalent 
bonds between them but are intertwined such that neither network can be separated from 
the other without breaking the covalent bonds of either individual polymer network 
[175].  Additionally, IPN synthesis involves sequential (polymerization of one network, 
infiltration of second network precursor) or simultaneous (both networks polymerized at 
the same time through non-interfering mechanisms) polymerization methods, the latter 
of which is thought to promote better homogeneity in the bulk gel structure [176].  IPNs 
of TRIS and DMA have been exploited in recent years as a way to create contact lenses 
with finer control over oxygen permeability and hydration in the lens material.  
Nicholson and Wang described the TRIS and DMA construct morphology as isotropic 
yet heterogeneous, with distinct, intertwining, hydrophobic silicone domains and 
hydrophilic DMA domains. This allowed transport between the two domains on the 
molecular scale, resulting in high oxygen transport properties in the overall gel [165, 
177]. Coincidentally, the same oxygen diffusion properties are desired for the 
subcutaneous, fully implantable biosensors described above. 
Sphere-templated hydrogels have been used as tissue-integrating constructs for a 
variety of tissue engineering applications. These templated hydrogels exhibit an inverted 
colloidal crystal structure that uses the scaffold morphology to promote angiogenesis 
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throughout the construct and avoid using anti-inflammatory agents or growth factors, 
which increase material cost, complicate the device fabrication process, and have limited 
use due to a limited drug payload and limited control over bioactivity and spatiotemporal 
distribution [178]. Materials used in these studies include pHEMA, poly(NIPAAm) and 
poly(acrylic acid), among others [24, 69, 70, 73, 179-181]. While these materials have 
shown cellular infiltration, some studies report zones of cellular necrosis in the scaffolds 
likely due to nutrient transport limitations (e.g., oxygen and glucose) [180]. Somo et al. 
investigated larger pore sizes (>100 µm) in similar inverted colloidal crystal hydrogels 
and reported that the interconnection between the pores has a profound effect on the 
penetration of these blood vessels throughout a sphere-templated gel [182]. In all studies 
noted above, the scaffolds consisted of the polymer matrix alone and were not 
functionalized with any optical sensing chemistry. By introducing an oxygen indicator, 
relationships between tissue ingrowth and oxygen permeability may be determined by 
fabricating these hydrogels as biosensors. 
The aim of this study was to use the two oxygen-permeable materials described 
in Chapter 4, DMA and TRIS, and use them to fabricate hybrid inorganic-organic 
silicone-containing IPN hydrogels. In this section of work, these gels were nctionalized 
with the oxygen-quenched phosphor PdBP. Various chemical properties were evaluated 
(water content, optical clarity, substrate transport, mechanical properties, and overall 
device performance) and compared to pHEMA-based biomaterials functionalized with 
the same sensing chemistry. Capitalizing on the synergistic behavior between the 
hydrophobic, inorganic TRIS alkylsiloxane and the hydrophilic, organic DMA in an IPN 
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gel structure, the ability to control gel hydration and mechanical properties 
independently from substrate (oxygen) transport is investigated. By utilizing an inverted 
colloidal crystal scaffold, proof of concept of these devices as long-term, tissue-
integrating implants is investigated as well.  
5.2. Experimental Methods 
5.2.1. Reagents and Instrumentation 
For photocuring, the UV lamp (Blak Ray-B-100 SP) was purchased from UVP-
LLC (Upland, CA). DMA, Nile Red, Irgacure 651, and PBS were purchased from Sigma 
Aldrich (St. Louis, MO). TRIS was purchased from Silar Laboratories (Wilmington, 
NC). TEGDMA was purchased from Polysciences (Warrington, PA). PdBP and 
poly(methyl methacrylate) (PMMA) beadcakes were provided by PROFUSA, Inc. Prior 
to use, DMA, TRIS, and  
Figure 5-1: Illustration of the hybrid inorganic-organic IPN gel fabrication process 
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TEGDMA were passed separately through individual inhibitor removal columns (Sigma) 
to remove the hydroquinone monomethyl ether (MEHQ) inhibitor. All other reagents 
were used as received unless otherwise stated. 
5.2.2. Interpenetrating Network Hydrogel Fabrication 
The IPN gels were fabricated using methacrylate-based monomers/crosslinker 
and a free-radical polymerization, similar to that described in previous sections but with 
a few changes [24, 65]. This section describes the synthesis of IPN hydrogels using a 
sequential polymerization process illustrated in Figure 5-1. 
In a typical synthesis, appropriate amounts of TRIS and DMA were added to 
Irgacure 651 (1:99 w/v% initiator:monomer) and vortexed to dissolve the photoinitiator. 
Next, TEGDMA was added as a crosslinker (2:98 v/v% crosslinker:monomer). All 
monomer and crosslinker materials were passed through an inhibitor removal column 
(Sigma) to remove the MEHQ inhibitor. PdBP was dissolved in dichloromethane (DCM) 
at a concentration of 10 mM; 25 µL of dye solution was added to the precursor solution 
and vortexed to mix. Finally, appropriate amounts of DCM and isopropanol (IPA) were 
added; necessary amounts of each solvent were determined based on the ratio of 
TRIS:DMA used. A too-high IPA content renders the gel tacky and unmanageable, 
whereas a too-high DCM content renders the gel too brittle and unable to be removed 
from the glass slide mold. TRIS:DMA ratios and corresponding cosolvent ratios are 
summarized in Table 5-1. Finally, the precursor solutions were purged with nitrogen gas 
for three minutes, transferred via pipette to a glass slide mold consisting of a Teflon  
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Table 5-1: Table of IPN formulations 
 
spacer (760 µm thick) secured with clips, and photopolymerized for 10 minutes (five 
minutes per side). 
Following photocuring, the gel slabs were removed from the mold, placed in a 
second precursor solution (3-mL total volume; 50:50 v/v% DMA:IPA; 98:2 v/v% 
DMA:TEGDMA; 1:99 w/v% Irgacure 651:DMA), and allowed to soak on a tabletop 
shaker overnight. The next day, the soaked gel (Figure 5-1B) permeated with the second 
DMA precursor was blotted on a Kimwipe to remove excess surface DMA precursor; it 
First Network Second Network Morphology 
Sensing 
Chemistry 
Co-
Solvents 
Monomer:Solvent 
Ratios (v:v) 
50:50 
TRIS:DMA 
pDMA 
homopolymer 
IPN 
10 mM 
PdBP in 
DCM 
75 µL 
IPA;  
50 µL 
DCM 
1:1.04 
60:40 
TRIS:DMA 
pDMA 
homopolymer 
IPN 
10 mM 
PdBP in 
DCM 
62.5 µL 
IPA; 62.5 
µL DCM 
1:1.04 
70:30 
TRIS:DMA 
pDMA 
homopolymer 
IPN 
10 mM 
PdBP in 
DCM 
50 µL 
IPA;  
75 µL 
DCM 
1:1.04 
80:20 
TRIS:DMA 
pDMA 
homopolymer 
IPN 
10 mM 
PdBP in 
DCM 
37.5 µL 
IPA; 87.5 
µL DCM 
1:1.04 
pHEMA 
homopolymer 
N/A 
Single 
network 
10 mM 
PdBP in 
DMSO 
90 µL 
ethylene 
glycol; 
100 µL 
DI water 
1:1 
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was then photocured between two glass slides to form the second network. The resulting 
IPN gel was placed in PBS (100 mM, pH 7.4) overnight to hydrate. 
5.2.3. In Vitro Physical Characterization 
 Swelling Ratios 
Five discs from each monolith, both with dye and without dye (blank), were 
punched with a disposable biopsy punch (5-mm diameter, VWR). Each disc was blotted 
on a Kimwipe to remove excess water and was weighed on an analytical balance 
(Mettler Toledo, Model XS64) to obtain the hydrated mass. The gel discs were dried 
under the house vacuum overnight (>24 hours) and weighed again to obtain the dried 
weight (Wd). The EWC was calculated from the percent difference in the two weights 
according to the equation presented in Section 4.2.4.1  
 Optical Clarity 
Five-millimeter blank discs without PdBP dye of each formulation were placed 
in a 96-well flat-bottom polystyrene well plate, and 200 µL of PBS (Sigma, 10 mM, pH 
7.4) was dispensed over each gel. An absorbance scan was conducted in a plate reader 
(Tecan Model M200) from 400 to 850 nm. Absorbance values (A) were converted to 
transmittance (%T) values according to the following relationship. 
%𝑇 =  10(2−𝐴) 
 
 Confocal Laser Scanning Microscopy 
Staining of the gels with Nile Red was adapted from Bailey, et al. 2012, as 
described in Section 4.2.4.5, reiterated here for consistency. First, a 20 mg/mL solution 
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of Nile Red (Sigma) in methanol was dissolved in a dram vial by vortexing for one 
minute. A 75 µL aliquot of this dye solution was added to 8 mL of DI water in a 20 mL 
scintillation vial and vortexed for one minute. Next, the 8 mL solution was diluted by 
adding it to 120 mL PBS in a beaker under constant stirring. Gel discs (5 mm diameter) 
were punched from the IPN gels with a biopsy punch. Each disc was placed in a separate 
centrifuge tube filled with 50 mL of the diluted Nile Red solution in PBS and placed on 
a nutating mixer at room temperature for 24 hours. After 24 hours, the Nile Red solution 
in PBS was discarded, and the stained gel discs were placed in fresh centrifuge tubes 
with 50 mL fresh PBS, allowing to nutate at room temperature for 24 more hours. The 
washing process was repeated three times, and the discs were stored in PBS until 
imaging. 
CLSM images were taken on an Olympus FV1000 confocal microscope. 
Excitation of the Nile Red stained gels was accomplished with a helium-neon laser (543 
nm); emission was collected from 650-700 nm. Images were obtained 100 µm into the 
sample. 
 Differential Scanning Calorimetry 
Differential scanning calorimetry (DSC) (TA Instruments, Q200) was performed 
on blank hydrogel monolith strips of each formulation. The blank strips were dried in a 
2.5-mL microcentrifuge tube under the house vacuum for over 24 hours. Five to 10 mg 
of each dried gel strip was weighed into an aluminum TZero pan and was then sealed 
hermetically. Thermal scans were run from 20 to 200 °C at a ramp rate of 10 °C/min. 
Two heat/cool cycles were run for each sample; the first cycle served to erase any 
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previous thermal history in the polymer, while the second cycle was used to obtain the 
glass transition temperature (Tg). Tg values were calculated in the TA Universal Analysis 
software using the glass transition function. Data reported are the calculated midpoint 
values for each analysis (n = 3). 
 Rheometry 
Dynamic modulus analysis to determine the viscoelastic response was performed 
on three separate hydrogel discs (10 mm in diameter) of each formulation using a 
rheometer (Anton Paar, MCR 301). Excess moisture was carefully removed by blotting 
the sample with a Kimwipe before analysis. A stainless steel, parallel plate geometry 10 
mm in diameter was used for frequency tests over the range of 1 to 100 Hz at a constant 
strain amplitude of 1 Pa.  The temperature, 25 and then 37 °C, was controlled by a 
circulating water bath and built-in Peltier heater. 
 Scanning Electron Microscopy 
Gels were freeze-dried in liquid nitrogen then lyophilized (Labconco, Model 
7811020) to preserve scaffold morphology. After lyophilizing, the gels were vacuum-
dried, mounted on a scanning electron microscope (SEM) stand using carbon tape, and 
sputtercoated (Tedpella, Model Cressington 108) for one minute to generate a ~2 nm 
layer of gold. Gels were imaged at 10 kV under low vacuum (JEOL USA, Inc., JCM-
5000 Neoscape). 
 Oxygen Transport (Stern-Volmer Kinetics) 
Stern-Volmer oxygen diffusion experiments were carried out by immobilizing 
dye-loaded monolith gel strips in an acrylic sample chamber sealed with an o-ring and 
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secured with screws. Samples were immobilized in wells with o-rings flush with the side 
of the well. Oxygen modulation experiments were carried out in an incubator using a 
recirculating flow system similar to that previously described [183]. Oxygen levels were 
controlled using a mass flow controller with two gas flow lines: one to nitrogen and the 
other to house air. Oxygen levels were verified using a picoammeter (Unisense, 
Denmark).  Gas was bubbled into a 2-L Erlenmeyer flask filled with 1 L of PBS and 
sealed with a rubber stopper with three openings: two for liquid influent and effluent and 
one for the ceramic gas bubbling tube (VWR). 
5.2.4. In Vivo Characterization 
 Implantation and Oxygen Modulation 
In vivo oxygen modulation procedures were approved by the Texas A&M 
IACUC committee. A female Sinclair mini-pig was obtained from Sinclair Bio-
Resources (Columbia, MO), anesthetized with an injection of telazol (5 mg/kg) and 
buprenorphine (0.01 mg/kg), sedated, and intubated. Dorsal hair was shaved, and skin 
was cleaned and prepared for injections by brushing with dye-free ChloraPrep 
applicators (CareFusion, San Diego, CA). Anesthesia was maintained with 1.0 to 2.5% 
isoflurane (v/v in O2) to effect during sensor injections and oxygen modulation. Sensors 
were injected subcutaneously into the dorsum of the pig (42.0 kg, one year old) from an 
18-gauge cannula with a reverse-action plunger. The sensors were targeted for insertion 
at ~5 mm deep; average and standard deviation of implant depths were determined to be 
5.4 ± 1.9 mm from post-experiment histological evaluation of n = 60 implants (some 
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implants were used only as controls and for histology for separate studies and are not 
detailed here). 
Optical readers of the same custom-built lifetime detection system used for in 
vitro sensor testing were placed and adhered on the skin over the injected IPN and 
pHEMA oxygen biosensors and allowed to collect baseline signal. Systemic oxygen 
challenges were achieved through reduction of the fraction of inspired oxygen. At 
baseline, the animal was maintained at fiO2 = 1.00. The fiO2 was then reduced to 
approximately 0.15 (v/v balance N2) for up to 15 minutes. After the hypoxic period, the 
fiO2 was returned to 1.00. 
 Histology 
Following humane euthanasia of the animal, the dorsal pelt was removed via 
scalpel, and sensors were located using the custom-built lifetime detection system 
described previously. Once located in the pelt, tissue plugs containing the sensors were 
isolated with 8-mm biopsy punches. The tissue plugs were immediately placed in 
formaldehyde and sent to CVPath (Gaithersburg, MD) for histological processing. The 
histology slides were imaged using a slide scanner with a 20× objective (Mikroscan, 
Model S2). Images were digitally processed using standard imaging software (Aperio 
ImageScope, version 11.1.2.760). 
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5.3. Results and Discussion 
5.3.1. In Vitro Physical Characterization 
 Swelling Ratios and Optical Clarity 
Hydrogel discs of four IPN formulations, both with and without the 
tetramethacrylated PdBP dye, were tested for water content. Figure 5-2 shows a general  
Figure 5-2: Swelling (top) and optical clarity (bottom). Swelling data represent 
triplicate averages; error bars represent 95% confidence intervals. 
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decrease in overall water content (EWC) with increasing TRIS content. This trend was 
expected because of the hydrophobic nature of TRIS; thus, a gel with higher TRIS 
content should imbibe less water than those with higher DMA content relative to TRIS. 
With the exception of 60:40 and 70:30 TRIS:DMA, the presence of the PdBP dye does 
not significantly affect the swelling ratio (p < 0.05). Regardless of TRIS:DMA ratio, all 
IPN gels were significantly more hydrated than pHEMA single-network gels. This was 
expected because of the highly hydrophilic nature of DMA compared to pHEMA, shown 
in previous studies using DMA as a wetting agent for contact lenses [72, 148, 167, 169, 
176]. Transmission spectra showed that with 70 to 80% TRIS content, the gels began to 
lose optical clarity over all wavelengths tested. However, 60:40 and 50:50 TRIS:DMA 
gels both exhibited similar optical transparency behavior to pHEMA (%T values within 
2% of pHEMA for both formulations), including in the PdBP excitation/emission 
window (630 to 820 nm, denoted by dashed black lines, Figure 5-2, bottom). 
Additionally, the data suggest that the IPN morphology successfully prevented 
the phase separation and opacity characteristically reported in the literature for single-
network silicone hydrogels [148, 183]. Decreased transparency in gels with higher TRIS 
content (70 to 80%) was likely caused by incomplete crosslinking of the TRIS chains 
due to the highly branched structure of the TRIS pendant group causing steric hindrance 
effects, blocking access of unreacted methacrylate groups to free radicals and slowing 
the propagation of the free-radical polymerization. Steric hindrance effects have been 
reported in the literature in similar free-radical-initiated systems using ethylene-glycol-
derived crosslinkers [184]. While siloxane materials are notorious for their oxygen 
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permeability, free-radical polymerizations are inhibited by oxygen, as oxygen is an 
excellent free-radical scavenger. In the case of TRIS, a siloxane methacrylate, higher 
amounts of TRIS may have allowed enough oxygen back into the system to stunt the 
crosslinking with TEGMDA. In fact, oxygen inhibition in similar photocurable siloxanes 
crosslinked with ethylene-glycol-derived crosslinkers has been reported in research and 
in the coatings and resins industry [185]. In the current system, the polymer chains 
containing high amounts of TRIS may not have been fully crosslinked in the first matrix 
by the TEGDMA crosslinker due to either oxygen inhibition or steric hindrance effects. 
This could have prevented the second pDMA network from fully reinforcing the first 
silicone-containing network if polymer chains were not fully tethered to the first matrix, 
resulting in phase separation in the IPN hydrogels with higher TRIS content.  
Despite some variations in transparency with higher silicone content, it is evident 
that the second network, pDMA, prevents silicone phase separation, at least to some 
extent, based on the fact that previous work has shown substantial TRIS phase 
separation in a single network monolith hydrogel with only 20 vol% of TRIS [183]. All 
formulations here have higher TRIS contents and increased optical clarity, indicating 
that the IPN network morphology reinforces the silicone and prevents phase separation. 
This is consistent with previous TRIS-containing IPN hydrogel reports for contact lenses 
[176, 177]. 
 Homogeneity 
Confocal microscopy images (Figure 5-3) indicate some phase separation in the 
80:20 TRIS:DMA as expected from the loss in optical clarity indicated from the UV-Vis  
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measurements (Figure 5-2). Lighter regions of the confocal images indicate areas where 
more dye was sequestered within the gel. The 80:20 TRIS:DMA confocal image (Figure 
5-3D) shows darker spherical regions dispersed throughout a lighter bulk gel material.  
Figure 5-3: CLSM images of IPN hydrogels. Images were taken at 10× 
magnification. Sections corresponding to the ratio of TRIS:DMA are as follows: A = 
50:50, B = 60:40, C = 70:30, D = 80:20. 
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Confocal images of the other formulations appear much more uniform 
throughout the gel, despite a few dispersed defects throughout the gels (Figure 5-3 A-C). 
The phase separation behavior seen in the confocal images is contrary to the 
hypothesized mode of phase separation based on the phase separation behavior of the 
60:20:20 HEMA:NVP:TRIS gel in Section 4.3.2.1.3.   With the 60:20:20 
HEMA:NVP:TRIS gel, the dye-stained silicone regions were located in the dispersed 
phase, and these silicone regions were distributed throughout the hydrophilic phase 
containing HEMA and NVP. Opposite phase separation behavior occurred here likely 
because four times as much silicone by volume was used to fabricate the 80:20 gels than 
in Chapter 4. This may allow the DMA to become the dispersed phase, with DMA-rich 
microdomains dispersed throughout the bulk material. Additionally, these IPN gels were 
made with a substantial amount of DCM as a precursor co-solvent (35 vol% of the total 
precursor solution). In previous studies of hybrid inorganic-organic silicone hydrogels, 
solvent-induced phase separation was desired and accomplished by using DCM as the 
primary solvent in the precursor solution. This allowed the silicone to remain in the 
continuous phase; similar behavior is seen here [154, 155]. To facilitate viewing of the 
three-dimensional distribution of the inhomogeneities throughout the IPN gels, montages 
of 20 single-slice confocal microscope images are shown in Figure 5-4; distance (depth) 
between sequential images is 5 μm. 
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A 
B 
Figure 5-4(A-B): Montages of CLSM images on IPN gels. Sections 
corresponding to the ratio of TRIS:DMA are as follows: A = 50:50, B 
= 60:40, C = 70:30, D = 80:20. 
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C 
D 
Figure 5-4 (continued, C-D): Montages of CLSM images on IPN 
gels. Sections corresponding to the ratio of TRIS:DMA are as follows: 
A = 50:50, B = 60:40, C = 70:30, D = 80:20. 
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 Thermomechanical Properties 
Figure 5-5 A-B show the real elastic modulus (G’) and imaginary viscous 
modulus (G”) results for all formulations tested within their viscoelastic region. As 
expected, all G’ values were found to be higher than their associated G” values, 
indicating a predominantly elastic response in all IPN formulations [186]. Neither G’ nor 
G” for the 50:50 and 60:40 TRIS: DMA formulation at 25 °C were significantly 
different (t-test, α = 0.05). Increasing temperature resulted in an overall decrease in both 
G’ and G”; elevated temperatures have been shown to transform the hydrogel from its 
rigid, glassy state to a more flexible, rubbery state, resulting in increased chain mobility 
and decreased storage and loss modulus [187]. Additionally, there was a slight decrease 
in modulus with a decrease in TRIS content at the tested frequencies, trending similarly 
to water content results shown previously (Figure 5-2); a decrease in the hydrophobicity 
of the IPN (increase in TRIS content) resulted in a decrease in both G’ and G”. It is 
important to note the slight increase in G’ with increasing frequency for the 80:20 
TRIS:DMA IPN, indicating physical, mechanical hindrance of the bulky TRIS 
sidechains at higher frequencies [188]. 
The DSC results (Figure 5-5E) showed no statistically significant difference (t-
test, α = 0.05) between the glass transition temperatures among 50% to 70% TRIS 
content, all three gels being around 112 °C. However, the gel with 80% TRIS exhibited a 
significantly depressed Tg, dropping around 50 °C lower than the three other IPN gels. 
This decreased Tg is attributed to the high siloxane content of the 80:20 formulation, as 
siloxane bonds are known for their remarkable torsional flexibility, and the branched 
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TRIS pendant group structure is known for its plasticizing ability [163, 164, 166]. 
Although a steady decline in Tg with increasing siloxane content was predicted, the 
behavior seen in Figure 5-5 could be due to the fact that the siloxane linkages were in the 
polymer pendant groups, not in the backbone. Comparatively, PDMS has one of the  
Figure 5-5: Dynamic mechanical testing results composed of storage and loss 
moduli at 22 °C (A&C) and 37°C (B&D). Glass transition temperatures of dried 
gels (n=3 ± 95% confidence intervals) 
 117 
 
lowest Tg values among polymers; however, those siloxane linkages are in the polymer 
backbone. With TRIS, the polymer backbone is a vinyl backbone without siloxane 
bonds, which could justify the fact that depression of the Tg was not seen until the first 
network contained 80% TRIS. Because Tg is characterized by increased segmented 
mobility of the polymer backbone, a stronger correlation between Tg and siloxane 
content may be seen with a polymer containing a siloxane backbone (e.g., PDMS). 
Furthermore, the entire second network is pDMA; Tg values for 50% to 70% TRIS are 
similar to Tg values reported for pDMA homopolymers [189]. This suggests that DMA 
mechanical properties dominate the overall mechanical behavior of the IPNs in this 
study. 
 Oxygen Transport—Stern-Volmer Kinetics 
Figure 5-6 shows a drastic increase in oxygen permeability according to Stern-
Volmer diffusion kinetics, as evidenced by the increased linear slopes (KSV values) of all 
IPN formulations versus the pHEMA standard. Specifically, the IPN monoliths exhibited  
an average 256% increase in oxygen permeability based on KSV and a 210% increase 
based on kq. Although the IPNs overall were significantly more permeable to oxygen 
than pHEMA (t-test, α = 0.05), among IPNs, all formulations were significantly different 
than pHEMA (t-test, α = 0.05). Comparing IPNs among themselves, only the 80:20 
formulation was found to be significantly different from 50:50 and 70:30; no other 
formulations showed statistical difference (t-test, α = 0.05). These two anomalies  
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aside, the results indicate that one can maintain a significantly increased oxygen 
permeability (compared to pHEMA) with these hybrid IPN gels irrespective of the 
silicone content (Table 5-2). 
 
 
 
 
Figure 5-6: Stern-Volmer oxygen diffusion plots and in vitro figures of merit 
on oxygen sensor monoliths. Data represent averages (n=3) ± 95% confidence 
intervals. 
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Table 5-2: Figures of merit for IPN and pHEMA gels  
  
 
5.3.2. In Vivo Characterization 
 In Vivo Oxygen Modulation—Baseline Analysis 
Figure 5-7 shows baseline lifetime averages for all six IPN implants. There is a 
remarkable difference in baseline averages between the slab and ICC morphologies. For 
example, while the slab baseline lifetime ranged from 20 to 206 µs on day 34, the 
baseline lifetime of the ICC implants only varied by 11 µs among all three implants. 
Similar trends were observed for each subsequent timepoint. There was some variability 
in baseline lifetimes from day 0 to day 20 for both ICC and slab implants; however, this 
variability diminished by day 20, whereas slabs did not assume this uniformity. 
 In Vivo Oxygen Modulation—Real-time Excursions 
Real-time oxygen tracking data in Figure 5-8 show low baseline lifetimes (<50 
µs) for both slab and ICC implants after implantation (day 0). Initially, slab sensors 
exhibited low sensitivity to oxygen with only a 15-µs change in measured 
phosphorescence lifetime. However, the response sensitivity improved drastically over 
Figure of 
Merit 
50:50 
TRIS:DMA 
60:40 
TRIS:DMA 
70:30 
TRIS:DMA 
80:20 
TRIS:DMA 
pHEMA 
KSV (µM-1) 0.112 ± 0.007 0.086 ± 0.019 0.084 ± 0.006 0.083 ± 0.002 0.0256 ± 0.002 
τ0 (µs) 267 ± 4 276 ± 20 307 ± 11 307 ± 5 248 ± 2 
kq              
((µs-µM)-1) 
4.18E-04 ± 
0.30E-04 
3.15E-04 ± 
0.82E-04 
2.75E-04 ± 
0.18E-04 
2.70E-04 ± 
0.05E-04 
1.03E-04 ± 
0.08E-04 
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time for the monolith slab implants, reaching up to a 245-µs change in measured 
Figure 5-7: Baseline lifetimes of all six IPN implants over 72 days. 
[Grab your reader’s attention with a great quote fr m the document or use this space 
to emphasize a key point. To place this text box anywhere on the page, just drag it.] 
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phosphorescence lifetime during modulation (over 1500% improvement from the initial 
Figure 5-8: Top: Real-time oxygen sensor response profile at 100% inspired oxygen 
(baseline) and 15% inspired oxygen (modulation) for two representative slab and ICC 
implants. Modulation time is indicated by shaded regions. Bottom: Luminescence lifetime 
averages immediately before starting oxygen modulation experiment. Data represent 
average (n=10 data points) ± 95% confidence intervals. 
[Grab your reader’s attention with a great qu te from the document or use this space to 
emphasize a key point. To place this text box anywhere on the page, just drag it.] 
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time for the monolith slab implants, reaching up to a 245-µs change in measured 
phosphorescence lifetime during modulation (over 1500% improvement from the initial 
modulation level). These trends rise from the differences in morphology between the 
slab and ICC implants. The microporated architecture of the ICC tissue-integrating 
scaffolds afforded those implants a higher surface-area-to-volume-ratio which allowed 
blood from the fresh wound to penetrate the scaffold more rapidly after implantation,   
resulting in a quicker response to local changes in oxygen. This is substantiated by the 
resulting in a quicker response to local changes in oxygen. This is substantiated by the 
distinct response plateau around 130 µs at day 0 and the subsequent rapid decline to the 
baseline lifetime value upon resuming 100% inspired oxygen level, a trend that was not 
observed in the solid monolith implants. However, the sensor sensitivity (% modulation) 
increased for the solid implants as time progressed, attributed to the wound healing 
around the implant. As the tissue healed, the local oxygen levels decreased, rendering 
the dye more sensitive to changes in local oxygen, a known property of oxygen-
quenched porphyrins. 
Opposite trends were observed for ICC implants. ICC sensors exhibited high 
sensitivity initially (~100 µs change in lifetime during oxygen modulation). While most 
of this sensitivity was maintained after six days (within the acute immune response 
window), ICC sensors began to lose this sensitivity to oxygen as implantation time 
progressed and the tissue healed, leading to a more steady-state behavior and chronic, 
end-stage immune response. Although ICC sensor baseline lifetimes were higher and 
sensor sensitivity decreased, a higher degree of response uniformity was observed 
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compared to the solid monolith slab sensors.  This is due to the tissue-integrating nature 
of the ICC scaffold. While primarily used to promote angiogenesis throughout the ICC 
construct, increase in baseline lifetime and lower modulation may be due to some 
deposition of connective tissue (e.g., collagen) throughout the scaffold. As healing 
transitioned to the chronic immune response stage, the scaffold baseline lifetime became 
more consistent, but the sensitivity decreased (down to ~35 µs at day 72). While there 
was a sacrifice of sensor sensitivity based on change in signal level, the sensor response 
was relatively consistent from day 20 to day 76 for the tissue-integrating ICC scaffolds. 
 In Vivo Oxygen Modulation—Absolute and Percent Signal Changes 
Absolute lifetime changes (Figure 5-9) were determined by subtracting the 
baseline lifetime before modulation (average of 10 data points) from the peak lifetime 
(highest lifetime observed during the modulation, average of 10 data points). Percent 
modulation (Figure 5-10) was calculated by determining the percent increase in 
luminescence lifetime averages from baseline to peak signal during modulation (average 
of 10 data points for both baseline and peak signals). These calculations were performed 
for each timepoint measured. Trends are consistent with the real-time modulation data 
described in Section 5.2.4.1. Overall, the percent modulation was more variable from 
day to day with the solid slabs and more consistent in the long term with the ICC 
implants. However, the D1I2 sensor reached up to 1000% change in signal level, the 
highest change reported in vivo for the sensors in this work [65].  Furthermore, it is 
notable that the slab sensor with the highest percent change during modulation (i.e., the 
most sensitive, D1I2) was also the sensor with the lowest baseline lifetime throughout 
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the entire study. Conversely, the slab sensor with the highest baseline lifetime in the long 
term was also the sensor exhibiting the lowest percent change and lowest sensitivity. It is 
important to keep in mind that these conclusions are drawn based on the percent change 
values, and the baseline values vary among the slab implants. Similar trends were 
observed when calculating the absolute lifetime change for all implants. However, all 
Figure 5-9: Absolute Lifetime change over time for all slab and ICC implants 
Figure 5-10: Percent modulation versus implantation time for all slab and ICC implants. 
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slab sensors reached a peak lifetime between 230 and 260 µs, regardless of the starting 
baseline lifetime value. This is reasonable considering that the natural lifetime, τ0, values 
were calculated at 275 ± 20 µs for the 60:40 TRIS:DMA formulation and the inspired 
pig oxygen level during modulation was 15% oxygen. 
For the ICC implants, percent modulation significantly decreased (about an order 
of magnitude), but this was likely due to higher surface area contact of connective tissue 
ingrowth throughout these tissue-integrating implants. Additionally, the percent  
modulation and absolute lifetime changes are more consistent for all three sensors 
among all timepoints. This behavior correlates with the baseline signal consistency 
observed in Figure 5-7 among the ICC implants. 
 Biocompatability—Relationship between Morphology and Foreign Body 
Response 
Inverted colloidal crystals were fabricated by using a partially-fused microsphere 
template (called a “beadcake”) as a sacrificial template to create porous scaffolds with 
highly uniform pore spacing.  Sintered PMMA beads (80 μm in diameter) were used as 
the beadcake material to synthesize all IPN ICC hydrogels in this study. A precursor of 
the first network was dispensed over the beadcake in a Teflon mold. The hydrogel and 
template were removed from the mold and soaked in a precursor solution of the second 
network, DMA. After overnight soaking, the beakcake/gel composite was blotted 
thoroughly on a Kimwipe to remove all of the excess DMA precursor and polymerized 
as in Section 5.2.2. After the second photocuring process, the hydrogels were placed in a 
solution of DCM overnight for dissolution of the remaining sintered beads. Figures 5-11 
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A&B consist of SEM images confirming an average pore size of 50 μm after freeze-(A- 
C A B 
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C D 
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G H 
Figure 5-11: SEM images of ICC and slab surface, respectively, at 100× and 540× 
(A&B) and 20× (C&D) magnification. Histology images of both ICC and slab 
hydrogels after explantation: Haemotoxylin and Eosin-stained images (E&G) show 
the presence of tissue ingrowth (pink) and cell nuclei (purple) while Masson’s 
Trichrome stained images (F&H, 20×) further differentiate the presence of loosely-
woven collagen (blue) and cellular penetration (red). 
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A and B consist of SEM images confirming an average pore size of 50 µm after freeze-
drying and lyophilization. The slight decrease in pore size was attributed to vacuum-
drying of the hydrogels in the lyophilizer. Not only do ICCs generate highly uniform 
pore structures, but they also have interconnects (Figure 5-11A-B), which are necessary 
for tissue ingrowth [179]. SEM images of slab hydrogels, shown in Figures 5-11 C and 
D, were included for comparison and showed a smooth surface, lacking the pores 
necessary for tissue integration and vascularization. 
Tissue integration through the oxygen sensor is thought to extend the sensor 
lifetime by providing a constant supply of oxygen due to circumventing the fibrous 
encapsulation caused by the foreign body response.  Figure 5-11E shows tissue ingrowth 
throughout the pores of the ICC implant, as indicated by the red color (H&E stain) 
interspersed throughout the implant image. Additionally, Figure 5-11F shows loosely-
packed collagen indicated by the light teal/blue fibrous structured regions (Mason’s 
Trichrome stain) surrounding the implant. On the contrary, the slab histology H&E stain 
in Figure 5-11G demonstrates a pink encapsulation layer dotted with dark purple cell 
nuclei, indicating the presence of an immune response. The trichrome stain of the slab 
implants in Figure 5-11H reveal densely-packed collagen and cell nuclei around the 
implant, characteristic of typical fibrosis response to a solid sensor implant [66, 125, 
126, 190]. 
5.4. Conclusions 
This chapter demonstrates the ability to fabricate hybrid inorganic-organic IPN 
silicone hydrogels as optical biosensors. Through in vitro characterization, these 
 128 
 
hydrogels have been shown to significantly increase the oxygen permeability to the 
pHEMA standard when functionalized with a long-lifetime, oxygen-quenched phosphor. 
This work further demonstrated the ability to maintain increased oxygen permeability 
while altering gel hydration, glass transition temperature, and mechanical properties, key 
novelties from previous single-network gels (Chapter 4) where water content and 
substrate transport directly influenced each other, and inhomogeneities within the gel 
matrix curtailed the oxygen transport and dynamic range of the sensors. 
Furthermore, fabrication of these hybrid IPN gels with an inverted colloidal 
crystal microarchitecture had not been demonstrated with a sequential polymerization 
process prior to this work. These inverted colloidal crystal oxygen-sensing scaffolds 
were shown to promote tissue ingrowth and vascularization throughout the scaffold, 
showing much more loosely-packed collagen surrounding the implants versus the 
densely-packed fibrous capsule typically found around solid implants which includes the 
IPN monolith sensor implants in this study. Both solid monolith and porous ICC 
implants responded to real-time oxygen modulations in vivo. Despite the unexpected 
sacrifice in sensor sensitivity (based on percent signal change during oxygen 
modulation) in vivo, the response among ICC implants became more repeatable and 
uniform due to the tissue integration. Loss in ICC sensitivity could be mitigated by using 
a beadcake consisting of PMMA microspheres of a different diameter (i.e., 40 μm).  
Smaller pores (i.e., 40 μm) have been used in other ICC implant studies, albeit not for 
biosensing applications and not in porcine models [70, 73, 179-181].  It is recommended 
for future preclinical trials that alternative pore sizes be investigated alongside 80-μm 
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diameter pores when fabricating IPN ICC sensors. Delving further into utilizing different 
pore sizes with these IPN ICC sensors will allow researchers to correlate the sensor 
sensitivity to local oxygen changes in real time as well as to the extent of fibrosis around 
and throughout the implants. This is useful not only from an exploratory standpoint, but 
also for the purpose of optimizing the repeatability and sensitivity of these oxygen 
sensors to ultimately transduce signals representative of other analytes besides oxygen 
(i.e., glucose and lactate).  
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6. CONCLUSIONS AND FUTURE WORK 
 
Proper substrate transport, retention of enzymatic apparent activity, and 
achieving proper balance between both diffusion and reaction are major barriers to 
achieving long-term sensor function in vivo. This dissertation presents the evaluation of 
three approaches toward achieving long-term in vivo function of a fully implantable 
CGM. Various sensor formulations and morphologies were tested by characterizing the 
underlying oxygen response and overall glucose response on the benchtop and in porcine 
models. Each aim of this work describes a different approach to evaluating feasibility on 
the benchtop and preclinical performance. 
6.1. pHEMA-co-AAm Single-Network Monolith Hydrogels 
In the first approach (Chapter 3), pHEMA-co-AAm gels were functionalized 
with a red-excitable assay consisting of GOx, CAT, and PdBP. Gels were subjected to a 
peroxide-based absorbance assay to assess apparent GOx activity and thermostability 
over a two-week period. A 75:25 HEMA:AAm formulation was chosen for further 
investigation. Stern-Volmer testing revealed a linear quenching trend (R2>0.99) at 
physiological oxygen levels, and in vitro glucose challenges revealed a distinct stair-step 
response in the hypo- and euglycemic ranges with high sensitivity and a quick response 
time (less than 10 minutes). Upon implantation in a porcine model, these sensors 
responded in real time to infusion of glucose via IV 2.5 hours after implantation, with 
the first report tracking rising and falling blood glucose levels in real time using a 
phosphorescence lifetime-based sensing platform. However, baseline lifetimes rose 
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significantly (more than 200 µs) after two weeks, and these sensors did not respond to 
glucose long term, which can be attributed to drastic decreases in the tissue oxygen 
levels surrounding the implant. After six weeks, these sensors were explanted and 
responded to glucose at physiological conditions, indicating that substrate transport 
balance, not total enzyme activity loss, was the cause for the lack of long-term response 
in vivo. Because this study was designed to show proof of concept in vitro and in vivo 
with the red-excitable glucose sensing assay, materials were selected based on previous 
studies with a similar assay (green-excitable), using a 75:25 HEMA:AAm copolymer as 
a “common middle ground” for both the enzyme and dye components of the sensor. 
Although it was shown that the GOx retained some activity after six weeks in vivo 
(evidenced by ex vivo testing), exactly how much GOx apparent activity was preserved 
was not apparent from the study’s design. The concentration of GOx and CAT used in 
this study was based on prior work [24] that did not describe a method to optimize 
enzyme concentration. Although sensor function ex vivo was maintained after six weeks 
in vivo, an excess of GOx in the sensor could mask the apparent activity loss and the 
fundamental enzyme stabilization efficiency of the gel. In fact, if an excess of GOx is 
used in the sensor, then loss in enzyme activity could be masked. While compensating 
for enzyme activity loss may appear valuable at first glance, from a production 
standpoint, this could lead to unused, wasted reagent in the sensor fabrication pipeline 
and could also affect the aforementioned reaction/diffusion balance. Therefore, a more 
fundamental study was designed to further understand the fundamentals of enzyme 
activity loss as a function of the ratio of GOx to the total protein in the sensor and as a 
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result of prolonged exposure to physiological conditions (glucose, pH, and temperature) 
with the rationale that probing deeper into the fundamentals behind GOx apparent 
activity retention over time will pave the way for a more thoughtful sensor design and 
accelerate the time to achieve long-term preclinical proof of concept. 
6.2. Alternative Single-Network Monolith Hydrogels 
The above questions directed the approach for Aim 2 (Chapter 4), which 
involved investigating a library of materials for feasibility in this long-term glucose-
sensing application by exposing the candidate materials to glucose (100 mg/dL) at 
physiological pH and temperature (where previous experiments only tested 
thermostability at physiological pH) to further replicate the in vivo environment and 
further investigate the efficacy of materials to better optimize GOx apparent activity 
long term. This second approach to refining sensor design started with identifying a 
library of promising material candidates, fabricating gels out of these candidates by 
incorporating various amounts of GOx into the precursor, and testing them weekly in a 
high-throughput o-dianisidine assay, incubating in physiological conditions between 
each assay timepoint. This study showed, surprisingly, that pHEMA and pHEMA-co-
AAm gels were the least effective in preserving GOx apparent activity, regardless of the 
concentration of GOx loaded in the gel. However, pHEMA-co-DMA and pHEMA-co-
NVP gels were more effective in preserving GOx activity, preserving 60 to 92% of the 
apparent activity after one week of incubation versus HEMA:AAm and HEMA 
homopolymer gels, which lost nearly all of their activity within the first week. Although 
this high-throughput assay method proved to be less sensitive to changes in GOx 
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concentration than originally anticipated, it served as a first-pass evaluation of a broad 
set of materials, revealing general trends between hydrogel formulation and GOx 
stability. Using this first-pass test to hone in on the most promising material candidates 
guided the development of more oxygen-permeable gel formulations, specifically ones 
with silicone (TRIS) and DMA. 
In conjunction with identifying gel formulations that simultaneously enhance 
GOx stability and oxygen permeability, other factors influencing sensor performance 
were revealed. Specifically, it was shown that matrix inhomogeneities can adversely 
affect sensor performance, reducing dynamic range and the oxygen permeability. This 
was apparent in the silicone-containing gels (60:20:20 HEMA:TRIS:NVP), where phase 
separation was observed and silicone domains acted to sequester oxygen. These silicone 
domains competed with the surrounding matrix for oxygen; instead of allowing the 
expected enhanced oxygen permeability, these inhomogeneities decreased the oxygen 
transport properties of the gel. These findings led to the investigation of ways to 
showcase the oxygen permeability properties of the siloxane monomer, explored in 
Chapter 5. 
6.3. Hybrid Materials—Summary and Future Improvements 
The third approach discussed in this dissertation to refine sensor design toward 
achieving long-term in vivo function involved creating hybrid inorganic-organic 
materials as IPNs to 1) prevent or reduce silicone phase separation throughout the gels 
and 2) introduce an added degree of control over the gel physicochemical properties, 
altering them independently of one another instead of the previously used one-step, 
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“brute force” sensor fabrication method. This study showed the ability to increase 
oxygen permeability throughout the gels by over 250% based on Ksv compared to 
pHEMA; this increase in permeability was maintained regardless of the amount of TRIS 
in the gel. Coincidentally, the water content and optical clarity decreased with increasing 
TRIS content, but still three times as much TRIS could be incorporated into the first 
network (60%) without a significant change in optical clarity properties compared to 
pHEMA in the relevant in vivo optical window. In comparison, the 60:20:20 
HEMA:NVP:TRIS gel investigated in Aim 2 showed phase separation even at only 20% 
TRIS. 
Decreased transparency in gels with higher TRIS content (70 to 80%) is likely 
caused by incomplete crosslinking of the TRIS chains due to the highly branched 
structure of the TRIS pendant group causing steric hindrance effects, blocking access of 
unreacted methacrylate groups to free radicals and slowing the propagation of the free 
radical polymerization. Steric hindrance effects have been reported in the literature in 
similar free-radical-initiated systems using ethylene-glycol-derived crosslinkers [184]. 
While siloxane materials are notorious for their oxygen permeability, free-radical 
polymerizations are inhibited by oxygen, as oxygen is an excellent free-radical 
scavenger. In the case of TRIS, a siloxane methacrylate, higher amounts of TRIS may 
have allowed enough oxygen back into the system to stunt the crosslinking with 
TEGMDA. In fact, oxygen inhibition in similar photocurable siloxanes crosslinked with 
ethylene-glycol-derived crosslinkers has been reported in research and the coatings and 
resins industry [185]. 
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While gelation time was shown to be affected by certain things like TRIS content 
and solvent ratios, one other factor to consider when considering the polymerization 
kinetics of this system is that free-radical polymerization is oxygen-inhibited. While all 
gel precursor solutions in this work were purged with nitrogen gas, the high oxygen 
permeability of the TRIS could decrease the efficacy of the nitrogen purge. Some air is 
introduced into the system when mixing the precursor with a pipette aspiration and 
dispensing the precursor into the mold. While this likely happens to some extent with all 
precursor formulations, the effect could be much more pronounced with the TRIS-
containing gels due to the high oxygen permeability. Two possible ways to overcome 
this are 1) polymerize the gel in a vacuum oven purged with nitrogen or 2) employ a 
polymerization mechanism that is not inhibited by oxygen. 
6.3.1. Alternative Polymerization Mechanism—Thiol-Ene Click Chemistry 
Click chemistry is a genre of synthesis reactions that capitalize on nature’s 
preference for carbon-heteroatom bonds over carbon-carbon bonds to give rise to 
materials with unique properties [191]. While carbonyl-based reactions, such as 
methacrylate polymerization, have traditionally been the focus of many synthesis 
applications, Click Chemistry has emerged as a focus to revolutionize molecular 
synthesis and expedite material fabrication processes [191-193]. Some applications of 
Click Chemistry include olefin synthesis, renewable or “green” polymer synthesis, bio-
orthogonal functionalization and telechelic biopolymer fabrication, and dental 
restoratives [194-196]. 
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Thiol-ene Click Chemistry has been used in the industrial coatings and resins, 
rubber manufacturing, and dental implant industries for many years, sometimes even 
being used in conjunction with epoxy-, vinyl-, or acrylate-based materials [197, 198]. 
One striking property of thiol-ene click reactions is that they are not inhibited by oxygen 
[192, 193, 197, 199]. Utilizing this property for creating the hybrid gels described herein 
could increase homogeneity and decrease gelation time since siloxanes are highly 
oxygen-permeable, and completely eliminating oxygen from the system during 
polymerization is difficult. While other click reactions, such as an alkyne-azide click 
reaction, could be useful for fabricating these gels, thiol-ene synthesis has been 
established with siloxane materials in the coatings and resins, photolithography 
manufacturing, and dental restoratives industries [198-200]. There are a wide variety of 
inexpensive vinyl and thiolated siloxane macromers commercially available that could 
be used for this application, which makes thiol-ene step-growth synthesis the most 
logical alternative to a random methacrylate-based addition synthesis, or at least to 
improve the efficacy of fabricating these hybrid materials with high silicone content. 
6.3.2. Simultaneous Polymerization 
Because the hybrid IPN gels described in this dissertation are made solely with 
methacrylate-based materials polymerized by the same mechanism, two separate curing 
steps were necessary to create two separate networks. This required soaking the gels in a 
second precursor solution to infiltrate the second network precursor components 
throughout the first as described in Chapter 5. This significantly delayed fabrication 
time, adding up to 24 hours to the fabrication process. One way to eliminate the need for 
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an overnight soaking time is to use two noninterfering polymerization mechanisms such 
that both networks can be polymerized simultaneously but independently, interweaving 
throughout each other without forming covalent bonds between the two networks. 
Various simultaneous polymerization mechanisms have been investigated for IPN 
polymers such as combining cationic and radical polymerization with acrylate, epoxy, 
and vinyl ether blends [201], with natural and synthetic materials using thiol click 
reactions [202], and even silicone-based materials such as PDMS and TRIS [203, 204]. 
Not only could using a simultaneous fabrication method increase fabrication time, 
eliminating the soaking step, but it could also allow for a more uniform matrix (without 
relying on external diffusion of a second precursor solution). Finally, eliminating a 
soaking stage in the fabrication process provides a more facile way to incorporate 
sensitive biomolecules, such as GOx, into the matrix; with the current sequential 
polymerization process, the organic solvent used in the IPN fabrication causes GOx to 
precipitate and denature [107, 205]. 
6.3.3. Introducing Glucose Responsive Functionality—Preliminary Studies 
One other avenue to be pursued with these IPN gels is to functionalize them with 
alternate sensing chemistries to detect analytes such as glucose. With the enzymatic 
assays discussed in this dissertation, adding enzymes to these IPN gels is no trivial task. 
A solution of GOx is typically made in aqueous buffer before adding to a gel precursor 
solution. However, these IPN gels cannot be fabricated with water because TRIS is 
immiscible with water. Therefore, one must dissolve the GOx in either DCM or IPA to 
incorporate it into the precursor solution, both solvents that cause GOx to precipitate out 
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of solution. In fact, IPA is used to precipitate enzymes for purification purposes [205]. In 
order to avoid GOx precipitation throughout the gel, the enzyme can be introduced to a 
system already immobilized in a vessel, such as a microsphere. The McShane lab has 
experience working with various types of microspheres for enzymatic immobilization. 
Immobilizing the GOx in a microsphere platform and then immobilizing the enzyme-
loaded sphere into the gel precursor can yield a gel with distinct, enzyme-containing 
microdomains within which GOx is evenly dispersed due to previously being 
immobilized before being introduced into the precursor. Preliminary results from 
incorporating these microdomains into IPN gels are presented below. 
 Nanofilm-Coated Capsules—Coprecipitation with Vaterite 
Some preliminary work has been done on immobilizing GOx in these IPN gels 
by introducing higher-order architectures as described above. Ideally, if GOx were to be 
introduced into the matrix using a microsphere, the sphere should be made of a material 
which can protect the GOx from the harmful organic solvents (DCM and IPA). For the 
preliminary work in this area, calcium carbonate microspheres were used to immobilize 
GOx and introduce the GOx into the IPN. Previously, the McShane lab has used calcium 
carbonate (vaterite) microspheres to as a mild, facile way to encapsulate sensing 
chemistry components, specifically GOx [206, 207]. When coated in a polymer film, 
such as a layer-by-layer (LbL) polyelectrolyte nanofilm, the calcium carbonate has been 
shown to be successfully dissolved as a sacrificial template, leaving behind a hollow, 
nanofilm-coated domain containing the desired cargo which was previously 
coprecipitated into the calcium carbonate sphere [25, 206-208]. It was hypothesized that 
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here, the crystalline structure of the calcium carbonate microspheres could be used to 
shield GOx from organic solvents, ultimately preserving GOx activity and leaving 
behind discrete, glucose-sensitive domains when the calcium carbonate core is 
dissolved.  
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6.3.3.1.1. Microcomposite Interpenetrating Network Hydrogel Fabrication 
GOx-containing vaterite microparticles were fabricated according to previous 
protocols [208], except poly (allylamine hydrochloride) (PAH) was labeled with 
rhodamine isothiocyanate (RITC) was used during the LbL self-assembly process for the 
purpose of visualizing the distribution of the microparticles in the gel.  LbL nanofilm-
coated vaterite microspheres, as well as the PdBP dye, were incorporated into the first 
Figure 6-1: Cartoon drawing of IPN microcomposite 
hydrogel and sacrificial template concept. 
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network of the IPN matrix due to their size microscale size; introducing them to the 
system in the second network is impractical because they would not be able to permeate 
the network (Figure 6-1). After immobilizing the sensing chemistry in the silicone-
containing first network, the composite gel was soaked in a DMA precursor as described 
in Chapter 5. In this preliminary study, three formulations of IPNs were investigated, 
altering the chemistry of the first network: 100:0 TRIS:DMA, 75:25 TRIS:DMA, and 
50:50 TRIS:DMA. Gel formulations are shown in Table 6-1 below: 
 
Table 6-1: IPN microcomposite precursor formulation components 
TRIS:DMA 
Ratio 
Vol. TRIS 
(μL) 
Vol. DMA 
(μL) 
Vol. TEGMDA 
(μL) 
Vol. PdBP 
(μL) 
Vol.  CaCO3 
suspension 
(μL) 
50:50 125 125 5 50 100 
75:25 187.5 62.5 5 50 100 
100:0 250 0 5 50 100 
 
 
The PdBP dye was dissolved in DCM at a concentration of 10 mM; the GOx 
CaCO3 suspension was fabricated in sodium bicarbonate buffer, but was washed in 
triplicate with IPA to remove the water and ensure miscibility of the capsule suspension 
with the other precursor components. The microparticle suspension itself was 
determined to contain 133 mg/mL of particles by weighing 30 μL aliquots in a 
microcentrifuge tube under house vacuum overnight. Higher TRIS contents were 
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focused on in this study because of the desire to limit glucose permeability as much as 
possible. Using a silicone material like TRIS not only enhances oxygen permeability but 
should also decrease glucose permeability because of its hydrophobicity, a logical 
postulation based on observations of swelling behavior with the IPN monolith oxygen 
sensors in Section 5.3.1.1.  
Because of the higher IPA content with these gels due to the capsule suspension, 
these gels were polymerized in the glass slide molds described previously, but the entire 
glass slide mold (clips and spacer removed) was placed in a 50-mL centrifuge tube and 
allowed to soak in the second network DMA precursor overnight on a nutating mixer. 
This was to preserve the morphology of the gel despite the “tackiness” imparted by the 
high IPA content. Gels were photopolymerized after soaking overnight, and the resulting 
IPN gel was removed from the mold after the second photocuring process. To dissolve 
the calcium carbonate core, the gels were hydrated in sodium acetate buffer at pH 5.1 
overnight.  
6.3.3.1.2. Morphological Characterization 
To observe capsule distribution throughout the matrix, confocal microscopy and 
SEM images were taken of the gels. The confocal image reveals closely packed, 
relatively monodisperse particles throughout the gel matrix, ca. 5 μm in diameter. 
Images were assigned red for contrast. Additionally, SEM images reveal hollow capsule 
morphology manifested as pores throughout the gel (Figure 6-2). 
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Figure 6-2: CLSM (top) and SEM (middle) images reveal distributed, hollow 
capsules (50:50 TRIS:DMA); Energy-dispersive spectroscopy (EDS) spectrum 
reveals presence of key elements (Si, O, N, C) and does not indicate presence 
of calcium. 
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While hollow pores were observed via SEM, determining the efficacy of calcium 
carbonate core dissolution is necessary. EDS results presented in Figure 6-2 indicate the 
presence of silicon, carbon, oxygen, and nitrogen, but no calcium peak was generated. 
The peaks present on the EDS spectrum expected based on the matrix chemistry. 
Absence of calcium supports the efficacy of sodium acetate dissolution of the CaCO3 
core and is consistent with the porous morphology seen in Figure 6-2.  
6.3.3.1.3. Apparent Glucose Oxidase Activity 
 Five discs from each formulation were subjected to screening for apparent GOx 
activity as described in Chapters 3 and 4. One advantage of using sodium acetate buffer 
to dissolve the sacrificial core is that this is the same buffer necessary to test for apparent  
 
Figure 6-3: Apparent activity measurements of 
capsule suspension and IPN composite gels. 
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activity using the o-dianisidine assay [129], and the gels are already equilibrated for  
testing using the assay. Shown in Figure 6-3, the 50:50 gels were found to be six times 
more active than the 75:25 gels, and the 100:0 gels showed effectively no apparent 
activity. Additionally, the 50:50 TRIS:DMA gels showed a three-fold decrease in 
apparent activity compared to the capsule suspension with an equivalent volume of 
particles used in the precursor solution (100 μL). The observed decrease in apparent 
activity in the gels is attributed to both the presence of the network restricting glucose 
influx throughout the particles and the possibility of some deactivation of GOx that may 
be immobilized on the surface of the particle during coprecipitation. 
6.3.3.1.4. Substrate Transport 
Stern-Volmer plots in Figure 6-4 indicate an increase with the 50:50 TRIS:DMA 
gel as expected from Chapter 5. However, consulting Table 6-2, the Ksv and kq values are 
nearly half that of those seen in Chapter 5. This is most likely because of the in-mold 
soaking used due to the high IPA content in the precursor to avoid disturbing the gel 
morphology. This soaking method may reduce the amount of water intake after 
polymerizing the second network. In the future, more batches of gels need to be made to 
determine if, in fact, the decrease in oxygen transport is correlated to hydration. In fact, 
Table 6-3 reveals that the 50:50 IPN composite gel is 45.8% less permeable to sucrose 
compared to pHEMA and 89.6% less permeable to sucrose compared to a 75:25 
HEMA:AAm gel. Because these were preliminary studies to investigate proof of concept 
with these microspheres in the IPN, evaluating trends between hydration and substrate 
was not a focus of this study but should be investigated in the future.  
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Table 6-2: IPN composite gel figures of merit compared to pHEMA and 75:25 
HEMA:AAm gels 
 
Table 6-3: Sucrose transport diffusion coefficients 
 
 
 
 
 
Formulation ID Ksv *10
–2 (µM)–1 kq*10
–5 (µM – µs)–1 τ0 (µs) 
100:0 HEMA:Aam 1.99 7.32 272.0 
75:25 HEMA:Aam 2.47 9.35 264.1 
50:50 TRIS:DMA IPN 5.34 21.0 254.1 
pHEMA 75:25 HEMA:Aam 50:50 TRIS:DMA IPN 
6.60 E–7 cm2/s 3.45 E–6 cm2/s 3.58 E–7 cm2/s 
Figure 6-4: Stern-Volmer plots of IPN microcomposite 
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6.3.3.1.5. Optical Response to Glucose 
To test sensors at physiological oxygen conditions, an in-line membrane degasser 
and vacuum pump were used, as illustrated in Figure 6-5. The membrane degasser was 
implemented to remove the dissolved air from the pump influent in order to decrease the 
oxygen levels closer to physiological oxygen. This was done in order to simulate the  
 
environment the sensors will experience in the subcutaneous tissue in vivo. Because the 
goal of this chapter is to describe ways to accelerate sensor feasibility testing and 
validation before implantation, mimicking the in vivo environment as closely as possible 
Figure 6-5: Scheme of low oxygen testing system used to 
determine overall glucose response at physiological oxygen levels. 
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is key to predicting how the sensors will perform in vivo over an extended period of time 
(i.e., weeks to months). 
To execute a low oxygen glucose challenge in vitro, buffer was flowed over the 
sensors for several hours while the pump, which was connected to the membrane 
degasser, removed dissolved gas from the buffer. In all low oxygen experiments, the 
sensor well closest to the effluent line was a pHEMA oxygen reference (pHEMA matrix 
functionalized with only PdBP, no enzyme); the other three wells were assigned glucose 
sensors (PdBP + enzyme microcapsules). The system was determined to be at “low 
oxygen” when the pHEMA oxygen reference reached at least 100 μs, the lifetime of 
pHEMA sensors at 5% oxygen, determined by Stern-Volmer experiments. It is worth 
noting that in order to remove enough dissolved gas from the system to reach 
physiological oxygen concentrations, the pump flow rate was decreased from 4 mL/min 
(at ambient oxygen) to 1.5 mL/min (low oxygen). This extended the runtime of each 
experiment from 3 hours to over 20 hours (at least 8 hours of baseline equilibration at 
low oxygen plus 2 hours of runtime at each glucose concentration). While this is not 
ideal from a throughput standpoint, more refined degassing systems can be implemented 
and are recommended for future studies. The data presented in this chapter were used to 
gain preliminary knowledge of sensor profiles at low oxygen. 
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It is noteworthy that the baseline lifetime (0 mg/dL glucose) hovers around 40 
µs, similar to the baseline lifetime of pHEMA sensors at ambient oxygen concentrations 
(Figure 6-6). In other words, while the baseline lifetime of pHEMA rises above 100 µs 
at 5% oxygen, the IPNs exhibit phosphorescence lifetime behavior similar to that of 
pHEMA at ambient conditions. However, upon exposing the IPNs to 50-mg/dL glucose, 
the lifetime signal drastically increases and plateaus, failing to respond at higher glucose 
concentrations. However, in all three sensor strips, the glucose response plateaus below 
the natural lifetime of PdBP (measured to be 254.1 μs by Stern-Volmer). This indicates 
that the system is reaction-limited rather than substrate-limited (Figure 1-1). Adding 
Figure 6-6: Optical response of the 50:50 TRIS:DMA sensors at 
physiological oxygen (5%) based on Stern-Volmer measurements. 
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more GOx capsules in the gel and tuning the permeability of the nanofilms and the 
matrix itself could allow further extension of the dynamic range of these sensors.  
6.4. Future Work and Recommendations on Design Principles 
Based on the results described in this dissertation, it is recommended that 
pursuing higher-order architectures such as IPNs and microcomposite gels is the best 
prospective method for achieving long-term function of a fully implantable enzymatic 
biosensor at physiological conditions using an enzyme/porphyrin sensing platform. 
Because of the complex nature of the sensing platform, higher-order systems impart the 
necessary control to optimize conditions for each sensing chemistry component 
individually. The hydrophilicity of enzymes and their ability to denature in harsh 
conditions juxtaposed with the hydrophobicity of the benzoporphyrin dye is an excellent 
paradigm for a composite system wherein discrete compartments can be implemented to 
efficiently immobilize the disparate molecules individually, yet incorporate both 
components into the same end structure (ideally without compromising the function of 
either encapsulated species). Furthermore, using a hybrid material, such as an IPN 
hydrogel matrix, adds degrees of control over sensor performance by allowing the 
alteration of matrix physicochemical properties independently of one another by altering 
the chemistry of one matrix or both matrices.  
Considering these points, it is recommended that future work be focused on 
refining this hybrid microcomposite design paradigm rather than a one-step, “brute-
force” synthesis. Fabrication of these hybrid composite sensors can be refined in several 
ways including the following: simultaneous polymerization, optimizing GOx 
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microparticle concentration and immobilization platform, and restricting glucose 
transport further by altering the bulk matrix chemistry and the permeability of the 
nanofilm coatings around GOx domains.   
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APPENDIX 
 
MATLAB Code for Extracting Time and Lifetime Arrays from In Vivo Oxygen 
Modulation Data Spreadsheets 
 
clear all 
close all 
clc 
 
%load data 
file = 'C:\Users\Rachel Unruh\OneDrive\Documents\Lab 
Docs\Kiwi\07072016\pHEMA\'; 
fn = 'Experiment160707105458_07072016_ReaderData_Channel1_WL1'; 
data = importdata([file '\' fn '.csv'],',',7); 
%step response - find response time 
time = data.textdata(:,1)'; 
time = time(:,8:length(time)); 
time=datenum(time)*24*60*60; 
starttime=time(1,1); 
for i=1:length(time) 
time(i,1)=time(i,1)-starttime; 
end 
time = time./3600; 
l1 = data.data(:,3)'; 
%i1 = data.data(:,2)' 
t=0; 
 
figure() 
hold on 
plot(time, l1) 
xlabel('Time (hrs)') 
ylabel('Lifetime (\mus)') 
 
Lifetime_Transposed = l1' 
 
 
 
 
 
 
 
 
 
 
 
 184 
 
MATLAB Code for Baseline and Peak Signal Analysis of In Vivo Oxygen 
Modulation Data 
 
clear all 
close all 
clc 
 
%Creates raw data variable arrays 
time = input ('Enter timepont values as a matrix: '); 
lifetime = input('Enter lifetime values as a matrix: '); 
 
%makes lifetime vs. time plot 
plot(time, lifetime); 
 
%enter how many times you changed the oxygen concentration in vivo 
N_peaks = input('Enter concentration number: '); 
 
%enter sequence of oxygen concentrations during oxygen modulation(s) 
%conc = input('Enter concentrations: '); 
 
%determines steady-state lifetime value ranges 
for i=1:N_peaks 
start(i)=input('Enter start time: '); 
done(i)=input('Enter end time: '); 
index=find(time>=start(i)); 
index1(i)=index(1); 
index=find(time<=done(i)); 
index2(i)=index(length(index)); 
 
h=line([start(i) start(i)],[min(lifetime) max(lifetime)]); 
set(h,'Color','g'); 
h=line([done(i) done(i)],[min(lifetime) max(lifetime)]); 
set(h,'Color','r'); 
x = (time(index1(i))+time(index2(i)))/2; 
%text(x, max(lifetime), num2str(conc(i)), 'HorizontalAlignment', 
'center', 'VerticalAlignment', 'bottom'); 
end 
 
%finds average lifetime value for each steady-state interval 
j=1; 
values = lifetime(index1(1): index2(1)); 
for i=1:N_peaks 
%if(conc(i)==conc(i+1)) 
%values = [values lifetime(index1(i+1):index2(i+1))]; 
%else 
m(j)=mean(values); 
n(j)=length(values); 
st(j)=std(values); 
e(j)=st(j)/sqrt(n(j)); 
 185 
 
confidence(j)=1.96*st(j)/sqrt(n(j)); 
p(j)=(m(j)-m(1))/m(1)*100; 
pst(j) = ((st(j)+m(j))-m(1))/m(1)*100-p(j); 
values = lifetime(index1(i+1):index2(i+1)); 
j=j+1; 
%end 
end 
m(j)=mean(values); 
n(j)=length(values); 
st(j)=std(values); 
e(j)=st(j)/sqrt(n(j)); 
p(j)=(m(j)-m(1))/m(1)*100; 
pst(j) = ((st(j)+m(j))-m(1))/m(1)*100-p(j); 
 
